https://invst.ly/zbgw-
https://invst.ly/zbmyz
https://invst.ly/zcazg
https://invst.ly/zdy3j
https://invst.ly/zdyt-
https://invst.ly/zdzdb
https://invst.ly/zfln4
https://uk.investing.com//news/stock-market-news/astrazeneca-shares-will-get-lift-from-heartburn-drug-litigation-closure-says-citi-2805533
https://uk.investing.com//news/stock-market-news/astrazeneca-touts-positive-data-from-two-experimental-drugs-in-breast-cancer-settings-2797029
https://uk.investing.com//news/stock-market-news/astrazenecas-beyfortus-receives-eu-approval-2811313
https://uk.investing.com//news/coronavirus/astrazeneca-says-evusheldapproved-for-treatment-of-covid19-in-eu-2755721
https://uk.investing.com//news/stock-market-news/astrazeneca-gets-its-third-regulatory-green-light-in-a-matter-of-weeks-for-asthma-drug-2762527
https://uk.investing.com//news/stock-market-news/astrazeneca-pays-660-premium-for-gene-therapy-firm-logicbio-2769321
https://uk.investing.com//news/stock-market-news/astrazeneca-pulls-plug-on-ionis-pharmapartnered-cholesterol-med-2760362
https://uk.investing.com//news/stock-market-news/astrazeneca-says-imjudoimfinzi-combination-approved-for-advanced-liver-cancer-in-us-2792403
https://uk.investing.com//news/stock-market-news/astrazenecamercks-prostate-cancer-combo-drug-3rd-try-for-scpharma-3-fda-panel-decisions-and-more-octobers-key-pdufa-catalysts-biotech-investors-must-know-2768564
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2756050_news_9
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2757318_news_8
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2785169_news_3
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2787067_news_2
https://uk.investing.com//news/stock-market-news/astrazeneca-on-hunt-for-oncology-cardiovascular-acquisitions-2729948
https://uk.investing.com//news/stock-market-news/astrazeneca-says-antibody-cocktail-backed-for-treating-covid-in-eu-2753079
https://uk.investing.com//news/stock-market-news/eu-backs-astrazenecas-drug-for-prevention-of-infant-rsv-2753065
https://uk.investing.com//news/stock-market-news/market-movers-property-groups-fall-as-goldmanjpmorgan-reduce-price-targets-2753709
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2729486_news_10
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2743281_news_8
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2743506_news_7
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2746030_news_6
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2750518_news_5
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2751629_news_4
https://uk.investing.com//news/stock-market-news/astrazeneca-cuts-innatepartnered-phase-3-trial-in-head--neck-cancer-2704512
https://uk.investing.com//news/stock-market-news/astrazeneca-says-lynparza-gets-eu-nod-to-treat-earlystage-breast-cancer-2709340
https://uk.investing.com//news/stock-market-news/daily-biotech-pulse-celyad-resumes-colorectal-cancer-trial-setback-for-otonomy-astrazeneca-halts-phase-3-head-neck-cancer-trial-2704505
https://uk.investing.com//news/stock-market-news/european-stocks-edge-higher-weak-chinese-data-hits-sentiment-2721075
https://uk.investing.com//news/stock-market-news/ftse-100-inches-higher-as-astrazeneca-counters-china-worries-2720983
https://uk.investing.com//news/stock-market-news/ftse-100-positive-but-off-early-highs-2721030
https://uk.investing.com//news/stock-market-news/ftse-100-positive-but-off-early-highs-2721030#comments
https://uk.investing.com//news/stock-market-news/sanofi-shares-slide-after-trials-of-potential-breast-cancer-drug-halted-2724515
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2709200_news_8
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2709255_news_7
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2711665_news_5
https://uk.investing.com//news/astrazeneca-adr-earnings-revenue-beat-in-q2-2702087
https://uk.investing.com//news/astrazeneca-earnings-revenue-beat-in-q2-2703094
https://uk.investing.com//news/stock-market-news/astrazeneca-beats-q2-profit-and-revenue-estimates-2701939
https://uk.investing.com//news/stock-market-news/astrazeneca-ceo-soriot-says-to-work-with-new-chairman-for-many-years-2702550
https://uk.investing.com//news/stock-market-news/astrazeneca-follows-the-trend-in-the-sector-to-upgrade-guidance-as-covid-vaccines-sales-show-resilience-2702042
https://uk.investing.com//news/stock-market-news/astrazeneca-q2-highlights-profits-fall-covid19-vaccine-sales-dip-lifts-annual-sales-guidance-2702306
https://uk.investing.com//news/stock-market-news/merck--astrazeneca-partnered-lynparza-fails-in-latestage-colorectal-cancer-study-2689928
https://uk.investing.com//news/stock-market-news/oil-producers-procter--gamble-astrazeneca-3-things-to-watch-2701478
https://uk.investing.com//news/stock-market-news/stellantis-tesla-astrazeneca-fall-premarket-exxon-mobil-rises-2681010
https://uk.investing.com//pro/offers/breaking-news-offer?referral=2703747_news_1
https://uk.investing.com//news/stock-market-news/astrazeneca-says-imfinzi-combo-shows-promise-in-latestage-lung-cancer-trial-2678710
https://uk.investing.com//news/stock-market-news/astrazeneca-to-buy-oncology-firm-teneotwo-for-up-to-127-billion-2680815
https://uk.investing.com//news/stock-market-news/astrazeneca-unveils-127b-purchase-of-us-biotech-firm-teneotwo-2680957
https://uk.investing.com//news/stock-market-news/astrazenecadaiichi-breast-cancer-drug-cuts-disease-progression-or-death-risk-by-almost-50-2663032
https://uk.investing.com//news/stock-market-news/european-stocks-drop-economic-activity-concerns-weigh-2680889
https://uk.investing.com//news/stock-market-news/new-data-sets-stage-for-broader-use-of-astrazeneca-breast-cancer-drug-2662634
https://uk.investing.com//news/stock-market-news/short-volatility-alert-astrazeneca-plc-2673770
https://uk.investing.com//news/stock-market-news/the-daily-biotech-pulse-thumbs-down-for-acadias-pimavanserin-pfizer-buys-stake-in-valneva-astrazeneca--ionis-eplontersen-aces-rare-disease-trial-2672805
https://uk.investing.com//news/stock-market-news/two-astrazeneca-drugs-get-eu-backing-for-treatment-of-some-breast-cancers-2676082
https://uk.investing.com//news/stock-market-news/two-astrazeneca-drugs-get-eu-backing-for-treatment-of-some-breast-cancers-2676082#comments
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-019-2678307
https://uk.investing.com//news/stock-market-news/astrazeneca-beats-quarterly-estimates-maintains-forecasts-2636388
https://uk.investing.com//news/stock-market-news/astrazeneca-says-eu-regulator-approves-covid-shot-as-booster-2654196
https://uk.investing.com//news/stock-market-news/astrazeneca-wades-deeper-into-covid-therapeutics-2650122
https://uk.investing.com//news/stock-market-news/cancer-treatments-may-benefit-from-lessons-of-pandemic-setbacks-astrazeneca-executive-2657560
https://uk.investing.com//news/stock-market-news/eu-health-regulator-backs-using-astrazeneca-covid-shot-as-booster-2652632
https://uk.investing.com//news/stock-market-news/former-astrazeneca-oncology-head-to-help-all-blue-in-zymeworks-takeover-bid-2639272
https://uk.investing.com//news/stock-market-news/innoviva-acquires-astrazenecaspin-off-at-220share-2654563
https://uk.investing.com//news/stock-market-news/the-daily-biotech-pulse-fda-approves-bristol-myers-oral-heart-disease-drug-european-approval-for-mercks-keytruda-genocea-restructures-zymeworks-takeover-bid-2636811
https://uk.investing.com//news/stock-market-news/the-daily-biotech-pulse-veru-shares-up-on-covid-candidate-update-fda-approves-lillys-covid-treatment-latest-on-sanofiastrazeneca-rsv-vaccine-2646328
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-145-2646514
https://uk.investing.com//news/astrazeneca-adr-earnings-revenue-beat-in-q1-2636523
https://uk.investing.com//news/astrazeneca-earnings-revenue-beat-in-q1-2636762
https://uk.investing.com//news/astrazeneca-tops-q1-eps-by-106-432SI-2636607
https://uk.investing.com//news/economy/inflation-and-gdp-in-the-eurozone-5-key-factors-this-friday-on-the-stock-market-2636375
https://uk.investing.com//news/stock-market-news/astrazeneca-antibody-cocktail-retains-activity-against-omicron-subvariants-2608713
https://uk.investing.com//news/stock-market-news/astrazeneca-antibody-cocktail-retains-activity-against-omicron-subvariants-2608713#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-clocks-q1-covid-vaccine-sales-of-12b-keeps-overall-fy22-outlook-2636645
https://uk.investing.com//news/stock-market-news/astrazeneca-inks-760-million-deal-with-swiss-firm-neurimmune-for-antibody-drug-2594931
https://uk.investing.com//news/stock-market-news/jim-cramer-gives-his-opinion-on-astrazeneca-intuitive-surgical-and-more-2630039
https://uk.investing.com//news/stock-market-news/uk-approves-astrazenecas-antibodybased-covid-treatment-2606845
https://uk.investing.com//news/stock-market-news/uk-approves-astrazenecas-antibodybased-covid-treatment-2606845#comments
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-038-2621634
https://uk.investing.com//news/stock-market-news/astrazeneca-chairman-leif-johansson-to-retire-in-2023-2589602
https://uk.investing.com//news/stock-market-news/astrazeneca-chairman-leif-johansson-to-retire-in-2023-2589602#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-gsks-covid19-therapies-lose-efficacy-against-omicrons-subvariants-2593038
https://uk.investing.com//news/stock-market-news/astrazeneca-signs-deal-with-canada-for-100000-doses-of-covid-drug-2591036
https://uk.investing.com//news/stock-market-news/astrazenecas-stock-gain-after-enhertu-meets-primary-endpoint-in-her2low-breast-cancer-setting-2589818
https://uk.investing.com//news/stock-market-news/exclusiveshort-astrazeneca-shelf-life-complicates-covid-vaccine-rollout-to-worlds-poorest-2586209
https://uk.investing.com//news/stock-market-news/exclusiveshort-astrazeneca-shelf-life-complicates-covid-vaccine-rollout-to-worlds-poorest-2586209#comments
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--british-american-tobacco-astrazeneca-deliveroo-2583411
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-101-2585773
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-043-2589237
https://uk.investing.com//news/stock-market-news/uk-stocks-recover-after-sharp-losses-astrazeneca-shines-2585307
https://uk.investing.com//news/stock-market-news/very-small-blood-clot-risk-after-first-astrazeneca-covid-shot--uk-studies-2590095
https://uk.investing.com//news/astrazeneca-earnings-revenue-beat-in-q4-2582731
https://uk.investing.com//news/coronavirus/astrazeneca-says-covid-vaccine-demand-high-in-latam-middle-east-asia-2582622
https://uk.investing.com//news/coronavirus/new-data-finds-astrazeneca-booster-generates-higher-antibodies-against-omicron-2561197
https://uk.investing.com//news/coronavirus/new-data-finds-astrazeneca-booster-generates-higher-antibodies-against-omicron-2561197#comments
https://uk.investing.com//news/stock-market-news/asian-stocks-down-bets-on-fed-interest-rate-hikes-continue-upward-trend-2579687
https://uk.investing.com//news/stock-market-news/astrazeneca-sees-2022-growth-but-covid-boost-to-drop-2582480
https://uk.investing.com//news/stock-market-news/astrazeneca-sees-2022-growth-but-covid-boost-to-drop-2582480#comments
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-anglo-american-fresnillo-2551205
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-anglo-american-fresnillo-2551205#comments
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-playtech-ocado-covid-update-2554949
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-unilever-rollsroyce-redrow-2582488
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-unilever-rollsroyce-redrow-2582488#comments
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--shell-astrazeneca-aston-martin-cc-2556938
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--unilever-gsk-taylor-wimpey-astrazeneca-2563367
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--unilever-gsk-taylor-wimpey-astrazeneca-2563367#comments
https://uk.investing.com//news/coronavirus/pfizer-set-to-oust-astrazeneca-as-top-supplier-of-covid19-shots-to-poor-nations-2538093
https://uk.investing.com//news/coronavirus/samsung-biologics-astrazeneca-expand-tieup-to-include-covid19-and-cancer-therapy-2536702
https://uk.investing.com//news/stock-market-news/astrazeneca-shot-third-dose-works-against-omicron-in-study-2546724
https://uk.investing.com//news/stock-market-news/astrazeneca-therapy-works-against-omicron-results-mixed-for-regeneron-2540179
https://uk.investing.com//news/stock-market-news/indias-billionaire-poonawalla-family-pledges-66-million-to-oxford-university-2538007
https://uk.investing.com//news/stock-market-news/indias-billionaire-poonawalla-family-pledges-66-million-to-oxford-university-2538007#comments
https://uk.investing.com//news/stock-market-news/oxford-astrazeneca-launch-work-on-omicrontargeted-vaccine-ft-2545151
https://uk.investing.com//news/stock-market-news/refugees-lack-covid-shots-because-drugmakers-fear-lawsuits--documents-2539384
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-gsk-rollsroyce-rio-tinto-2542702
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-schroders-gsk-bhp-foxtons-2544075
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-schroders-gsk-bhp-foxtons-2544075#comments
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--flutter-bhp-balfour-beatty-deliveroo-2546738
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--flutter-bhp-balfour-beatty-deliveroo-2546738#comments
https://uk.investing.com//news/coronavirus/astrazeneca-to-supply-covid19-antibody-cocktail-to-singapore-2533708
https://uk.investing.com//news/coronavirus/astrazeneca-to-supply-covid19-antibody-cocktail-to-singapore-2533708#comments
https://uk.investing.com//news/coronavirus/mixing-pfizer-astraz-covid19-shots-with-moderna-gives-better-immune-response--uk-study-2529496
https://uk.investing.com//news/coronavirus/uk-study-finds-mrna-covid19-vaccines-provide-biggest-booster-impact-2526562
https://uk.investing.com//news/stock-market-news/astrazeneca-hopeful-its-antibody-cocktail-will-work-on-new-covid-variant-2520799
https://uk.investing.com//news/stock-market-news/demand-still-strong-for-indiamade-astrazeneca-vaccine-doses--covaxs-gavi-2532416
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--bt-astrazeneca-darktrace-wpp-taylor-wimpey-2528526
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--glencore-easyjet-astrazeneca-wetherspoon-2522960
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--gsk-bats-astrazeneca-sse-babcock-2529714
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--gsk-bats-astrazeneca-sse-babcock-2529714#comments
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--omicron-bt-astrazeneca-aj-bell-hammerson-amigo-2521755
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-148-2530513
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-148-2530513#comments
https://uk.investing.com//news/astrazeneca-earnings-miss-revenue-beats-in-q3-2510547
https://uk.investing.com//news/coronavirus/astrazeneca-antibody-drug-works-to-prevent-covid19-in-longerterm-studies-2514978
https://uk.investing.com//news/coronavirus/astrazeneca-antibody-drug-works-to-prevent-covid19-in-longerterm-studies-2514978#comments
https://uk.investing.com//news/coronavirus/astrazenecaoxford-covid19-vaccine-supply-hits-two-billion-doses-2512646
https://uk.investing.com//news/economy/astrazeneca-drags-down-uks-ftse-100-2510379
https://uk.investing.com//news/stock-market-news/astrazeneca-vaccine-turns-profitable-drugmaker-banking-on-new-orders-2510321
https://uk.investing.com//news/stock-market-news/britains-prince-charles-to-open-new-astrazeneca-research-centre-2517913
https://uk.investing.com//news/stock-market-news/rate-worries-cap-gains-in-ftse-100-vodafone-up-on-earnings-beat-2512784
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-landsec-avon-protection-redrow-aveva-2510327
https://uk.investing.com//news/stock-market-news/uk-premarket-stocks-update--astrazeneca-landsec-avon-protection-redrow-aveva-2510327#comments
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-034-2513428
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-051-2510926
https://uk.investing.com//news/general/astrazeneca-to-transfer-some-drug-rights-to-covis-pharma-in-270-million-deal-2498342
https://uk.investing.com//news/stock-market-news/astrazeneca-earnings-job-openings-sentiment-3-things-to-watch-2510030
https://uk.investing.com//news/stock-market-news/astrazeneca-to-create-separate-division-for-vaccines-antibody-therapies-2507098
https://uk.investing.com//news/stock-market-news/european-stock-futures-edge-lower-us-inflation-earnings-in-focus-2506567
https://uk.investing.com//news/stock-market-news/inflation-worries-weigh-on-ftse-100-tesco-jumps-2478669
https://uk.investing.com//news/stock-market-news/inflation-worries-weigh-on-ftse-100-tesco-jumps-2478669#comments
https://uk.investing.com//news/stock-market-news/uk-market-update--cdr-wins-bid-for-morrisons-plus500-boosts-forecast-2476667
https://uk.investing.com//news/stock-market-news/uk-market-update--greggs-raises-forecast-melrose-warns-on-supply-constraints-2477716
https://uk.investing.com//news/stock-market-news/uk-market-update--greggs-raises-forecast-melrose-warns-on-supply-constraints-2477716#comments
https://uk.investing.com//news/stock-market-news/uk-market-update--hsbc-initiates-share-buyback-tesco-suffers-attempted-hack-2491730
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-025-2500175
https://uk.investing.com//news/stock-market-news/uk-update--rio-tinto-cuts-iron-ore-shipment-forecast-pearson-revenue-up-10-2485180
https://uk.investing.com//news/stock-market-news/uk-update--rio-tinto-cuts-iron-ore-shipment-forecast-pearson-revenue-up-10-2485180#comments
https://uk.investing.com//news/astrazeneca-earnings-miss-revenue-beats-in-q2-2429132
https://uk.investing.com//news/coronavirus/british-study-shows-covid19-vaccine-efficacy-wanes-under-delta-2446364
https://uk.investing.com//news/economy/fed-rattles-global-markets-jobless-claims-auto-chip-woe--whats-moving-market-2446630
https://uk.investing.com//news/stock-market-news/picky-vaccine-sommeliers-undermine-brazil-inoculation-campaign-experts-say-2413329
https://uk.investing.com//news/stock-market-news/uk-market-update--easyjet-rejects-takeover-offer-888-buys-william-hill-assets-2459859
https://uk.investing.com//news/stock-market-news/uk-market-update--easyjet-rejects-takeover-offer-888-buys-william-hill-assets-2459859#comments
https://uk.investing.com//news/stock-market-news/uk-market-update--moonpig-boosts-guidance-blue-prism-agrees-takeover-2472609
https://uk.investing.com//news/stock-market-news/uk-market-update--next-raises-guidance-unilever-shortlists-bidders-for-tea-unit-2473546
https://uk.investing.com//news/stock-market-news/uk-market-update--next-raises-guidance-unilever-shortlists-bidders-for-tea-unit-2473546#comments
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-117-2474152
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-117-2474152#comments
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-084-2467167
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-114-2417683
https://uk.investing.com//news/coronavirus/pfizer-cuts-norways-covid19-vaccine-deliveries-rollout-delayed-2392594
https://uk.investing.com//news/economy/pharma-names-lift-ftse-barclays-declines-usd-jumps-on-hawkish-kaplan-2361244
https://uk.investing.com//news/economy/pharma-names-lift-ftse-barclays-declines-usd-jumps-on-hawkish-kaplan-2361244#comments
https://uk.investing.com//news/economy/vaccine-ip-waivers-stealing-from-the-rich-to-give-to-the-poor-2371002
https://uk.investing.com//news/stock-market-news/denmark-to-reconsider-exclusion-of-jj-and-astrazeneca-shots-2384133
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-013-2361281
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-057-2409892
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-022-2391207
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-087-2405051
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-204-2351098
https://uk.investing.com//news/stock-market-news/walmart-profits-home-depot-sales-macys-outlook-3-things-to-watch-2375365
https://uk.investing.com//news/coronavirus/in-world-first-denmark-ditches-astrazenecas-covid19-shot-2346453
https://uk.investing.com//news/coronavirus/in-world-first-denmark-ditches-astrazenecas-covid19-shot-2346453#comments
https://uk.investing.com//news/coronavirus/watch-live-european-medicines-agency-press-conference-on-astrazeneca-jab-2341182
https://uk.investing.com//news/coronavirus/watch-live-european-medicines-agency-press-conference-on-astrazeneca-jab-2341182#comments
https://uk.investing.com//news/economy/bank-earnings-coinbase-goes-public-iea-hikes-oil-forecast--whats-up-in-markets-2346121
https://uk.investing.com//news/economy/bank-earnings-coinbase-goes-public-iea-hikes-oil-forecast--whats-up-in-markets-2346121#comments
https://uk.investing.com//news/economy/jobless-claims-powell-astrazeneca-vaccine--whats-moving-markets-2341959
https://uk.investing.com//news/stock-market-news/banks-chime-in-on-astrazeneca-amid-vaccine-news-2342234
https://uk.investing.com//news/stock-market-news/britains-medicine-regulator-will-recommend-halting-rollout-of-astrazeneca-shots-to-under30s-the-sun-and-sky-say-2341228
https://uk.investing.com//news/stock-market-news/eu-commission-to-end-astrazeneca-and-jj-vaccine-contracts-at-expiry--paper-2345917
https://uk.investing.com//news/stock-market-news/eu-commission-to-end-astrazeneca-and-jj-vaccine-contracts-at-expiry--paper-2345917#comments
https://uk.investing.com//news/stock-market-news/ftse-jumps-amid-weak-gbp-possible-link-found-between-az-jab-and-rare-blood-clots-2341337
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-089-2341370
https://uk.investing.com//news/stock-market-news/us-futures-edge-lower-on-jj-shock-crucial-inflation-data-looms-2345095
https://uk.investing.com//news/coronavirus/eu-will-tighten-restrictions-on-covid-vaccine-export-2331528
https://uk.investing.com//news/coronavirus/eu-will-tighten-restrictions-on-covid-vaccine-export-2331528#comments
https://uk.investing.com//news/coronavirus/watch-live-european-medicines-agency-press-conference-on-astrazeneca-jab-2327763
https://uk.investing.com//news/coronavirus/watch-live-european-medicines-agency-press-conference-on-astrazeneca-jab-2327763#comments
https://uk.investing.com//news/economy/covid19-surge-turkey-turmoil-gamestop-earnings--whats-up-in-markets-2329388
https://uk.investing.com//news/economy/covid19-surge-turkey-turmoil-gamestop-earnings--whats-up-in-markets-2329388#comments
https://uk.investing.com//news/economy/powell-yellen-testify-astrazenecas-vaccine-housing-data--whats-up-in-markets-2330339
https://uk.investing.com//news/economy/suez-jam-jobless-claims-astrazeneca-update--whats-up-in-markets-2332528
https://uk.investing.com//news/economy/suez-jam-jobless-claims-astrazeneca-update--whats-up-in-markets-2332528#comments
https://uk.investing.com//news/stock-market-news/european-stocks-mixed-eu-leaders-set-to-discuss-covid-2332416
https://uk.investing.com//news/stock-market-news/ftse-100-closes-higher-gbp-strong-suez-canal-remains-blocked-2333895
https://uk.investing.com//news/stock-market-news/ftse-100-closes-higher-gbp-strong-suez-canal-remains-blocked-2333895#comments
https://uk.investing.com//news/stock-market-news/ftse-100-closes-higher-midcaps-outperform-astrazeneca-jumps-oil-lower-2325747
https://uk.investing.com//news/stock-market-news/ftse-100-closes-higher-midcaps-outperform-astrazeneca-jumps-oil-lower-2325747#comments
https://uk.investing.com//news/stock-market-news/gamestop-new-home-sales-astrazeneca-3-things-to-watch-2330001
https://uk.investing.com//news/stock-market-news/rollsroyce-recent-strength-continues-after-jpmorgan-upgrade-2326438
https://uk.investing.com//news/stock-market-news/rollsroyce-recent-strength-continues-after-jpmorgan-upgrade-2326438#comments
https://uk.investing.com//news/commodities-news/crude-oil-lower-amid-recovery-concerns-api-data-in-focus-2325513
https://uk.investing.com//news/economy/ftse-100-slightly-lower-bitcoin-the-asset-in-focus-2297836
https://uk.investing.com//news/economy/ftse-100-slightly-lower-bitcoin-the-asset-in-focus-2297836#comments
https://uk.investing.com//news/forex-news/pound-rally-continues-as-cable-breaks-back-above-13900-2305231
https://uk.investing.com//news/stock-market-news/astrazeneca-denies-vaccine-delivery-shortfall-to-eu-italy--paper-2310773
https://uk.investing.com//news/stock-market-news/astrazeneca-shares-rise-to-the-top-of-the-ftse-despite-vaccine-concerns-2325222
https://uk.investing.com//news/stock-market-news/astrazeneca-shares-rise-to-the-top-of-the-ftse-despite-vaccine-concerns-2325222#comments
https://uk.investing.com//news/stock-market-news/ftse-100-finishes-lower-as-miners-weigh-bitcoin-retreats-from-alltime-high-2324713
https://uk.investing.com//news/stock-market-news/ftse-100-finishes-lower-as-miners-weigh-bitcoin-retreats-from-alltime-high-2324713#comments
https://uk.investing.com//news/stock-market-news/the-uk-stocks-benefiting-from-vaccinerelated-news-according-to-hsbc-2299250
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-031-2322638
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-038-2306680
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-265-2302575
https://uk.investing.com//news/coronavirus/uk-says-astrazeneca-vaccine-prevents-covid19-death-as-south-africa-halts-shots-2296688
https://uk.investing.com//news/coronavirus/uk-says-astrazeneca-vaccine-prevents-covid19-death-as-south-africa-halts-shots-2296688#comments
https://uk.investing.com//news/economy/ftse-100-maintains-march-higher-as-miners-rally-2296847
https://uk.investing.com//news/markets/ftse-100-broadly-flat-amid-decline-in-services-sector-activity-boe-in-focus-2293382
https://uk.investing.com//news/stock-market-news/astrazeneca-to-sell-its-holding-in-viela-bio-2291258
https://uk.investing.com//news/stock-market-news/european-medicines-agency-recommends-eu-approval-for-astrazeneca-vaccine-2290085
https://uk.investing.com//news/stock-market-news/european-stocks-higher-corporate-earnings-italian-politics-help-2293214
https://uk.investing.com//news/stock-market-news/eus-von-der-leyen-says-astrazeneca-will-deliver-9-million-more-vaccine-doses-2290737
https://uk.investing.com//news/stock-market-news/eus-von-der-leyen-says-astrazeneca-will-deliver-9-million-more-vaccine-doses-2290737#comments
https://uk.investing.com//news/stock-market-news/uk-plant-producing-astrazeneca-vaccines-partially-evacuated-over-suspect-package-2287523
https://uk.investing.com//news/stock-market-news/uk-plant-producing-astrazeneca-vaccines-partially-evacuated-over-suspect-package-2287523#comments
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-feb-8-2296713
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-feb-8-2296715
https://uk.investing.com//news/economy/asian-shares-pause-recent-rally-euro-near-212year-high-2273311
https://uk.investing.com//news/economy/mcconnell-defies-trump-uk-oks-astra-vaccine-bitcoin-ath--whats-up-in-markets-2273468
https://uk.investing.com//news/forex-news/pounds-hits-near-threeyear-high-against-the-dollar-2283195
https://uk.investing.com//news/forex-news/pounds-hits-near-threeyear-high-against-the-dollar-2283195#comments
https://uk.investing.com//news/stock-market-news/english-health-official-says-have-been-extracting-extra-doses-of-astrazeneca-vaccine-2277554
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-050-2271496
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-115-2276592
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-dec-22-2270544
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-dec-31-2273851
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-jan-4-2274638
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-dec-22-2270545
https://uk.investing.com//news/stock-market-news/pointcounterpoint-the-case-for-astrazeneca-2258221
https://uk.investing.com//news/stock-market-news/stockbeat-just-when-you-thought-it-was-safe-to-get-back-in-the-water-2264034
https://uk.investing.com//news/stock-market-news/stockbeat-just-when-you-thought-it-was-safe-to-get-back-in-the-water-2264034#comments
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-036-2261244
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-068-2266577
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-dec-1-2259372
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-dec-10-2264610
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-dec-21-2269886
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-dec-3-2260831
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-dec-21-2269910
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-nov-30-2258696
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-nov-30-2258696#comments
https://uk.investing.com//news/coronavirus/astrazeneca-covid19-shot-candidate-shows-promise-among-elderly-in-trials-2253491
https://uk.investing.com//news/coronavirus/oxfords-covid19-vaccine-trial-results-definitely-before-christmas--investigator-2253539
https://uk.investing.com//news/economy/black-friday-arrives-spanish-banks-turn-down-merger-opec-looms--whats-up-in-ma-2258037
https://uk.investing.com//news/economy/europe-confidence-slips-bitcoin-corrects-slack-talk--whats-up-in-markets-2257576
https://uk.investing.com//news/stock-market-news/dow-slips-on-concerns-over-recovery-with-weaker-jobs-restrictions-2254009
https://uk.investing.com//news/stock-market-news/pfizerbiontech-vaccine-deliveries-could-start-before-christmas-2253278
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-013-2255629
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-nov-24-2255933
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-nov-27-2257959
https://uk.investing.com//news/world-news/where-theres-a-will-theres-a-way-as-english-doctors-prepare-covid-vaccine-rollout-2253132
https://uk.investing.com//news/coronavirus/covid19-war-games-the-computer-program-that-could-help-save-your-job-2249277
https://uk.investing.com//news/coronavirus/indias-serum-says-produced-40-million-doses-of-astrazeneca-covid19-vaccine-2249739
https://uk.investing.com//news/coronavirus/oxford-ups-covid19-testing-capacity-with-thermo-fisher-deal-2248519
https://uk.investing.com//news/coronavirus/pfizer-and-biontech-say-their-covid19-vaccine-is-over-90-effective-2247711
https://uk.investing.com//news/coronavirus/pfizer-and-biontech-say-their-covid19-vaccine-is-over-90-effective-2247711#comments
https://uk.investing.com//news/coronavirus/why-i-volunteered-for-a-covid19-vaccine-trial-2249799
https://uk.investing.com//news/stock-market-news/eu-seals-deal-with-pfizerbiontech-for-supply-of-300-million-doses-of-covid-vaccine-2249271
https://uk.investing.com//news/stock-market-news/eu-to-okay-deal-with-curevac-for-supply-of-up-to-405-million-covid-vaccines-2251697
https://uk.investing.com//news/stock-market-news/exclusive-europe-to-pay-less-than-us-for-pfizer-vaccine-under-initial-deal--source-2249380
https://uk.investing.com//news/stock-market-news/pfizer-shares-drop-as-moderna-vaccine-seen-easier-to-distribute-2251752
https://uk.investing.com//news/uk-stocksfactors-to-watch-on-nov-10-2248288
https://uk.investing.com//news/coronavirus/argentina-agrees-deal-for-22-million-doses-of-astrazenecaoxford-covid19-vaccine-2247244
https://uk.investing.com//news/coronavirus/oxford-covid19-vaccine-trial-results-due-this-year-trial-chief-says-2245168
https://uk.investing.com//news/economy/investors-bet-vaccine-sparks-revival-in-beaten-down-stocks-2247477
https://uk.investing.com//news/economy/investors-bet-vaccine-sparks-revival-in-beaten-down-stocks-2247477#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-beats-thirdquarter-sales-estimate-backs-2020-outlook-2245734
https://uk.investing.com//news/stock-market-news/astrazeneca-beats-thirdquarter-sales-estimate-backs-2020-outlook-2245734#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-right-to-heart-failure-blood-pressure-medicines-for-400-million-2242626
https://uk.investing.com//news/stock-market-news/healthcare-gold-miners-fed-statement-3-things-to-watch-2245577
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-139-2245407
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-nov-2-2243648
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-nov-5-2245740
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-nov-6-2246593
https://uk.investing.com//news/coronavirus/astrazeneca-oxford-allowed-to-resume-covid19-vaccine-trial-in-us--wsj-2238879
https://uk.investing.com//news/coronavirus/astrazeneca-oxford-allowed-to-resume-covid19-vaccine-trial-in-us--wsj-2238879#comments
https://uk.investing.com//news/coronavirus/britain-expects-verdict-on-pfizers-covid19-vaccine-before-astrazenecas--times-2241595
https://uk.investing.com//news/stock-market-news/astrazeneca-says-its-oxford-vaccine-deal-allows-it-to-add-up-to-20-of-manufacturing-costs-2238960
https://uk.investing.com//news/stock-market-news/astrazeneca-says-its-oxford-vaccine-deal-allows-it-to-add-up-to-20-of-manufacturing-costs-2238960#comments
https://uk.investing.com//news/stock-market-news/dow-snaps-3week-win-streak-as-stimulus-jitters-stifle-bulls-2238908
https://uk.investing.com//news/stock-market-news/energy-stocks-drag-ftse-100-lower-as-virus-fears-weigh-2239406
https://uk.investing.com//news/stock-market-news/europe-prepares-for-more-pain-ahead-as-covid-surges-2239463
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-098-2239771
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-oct-26-2239350
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-oct-30-2242627
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-oct-29-2241745
https://uk.investing.com//news/coronavirus/britain-moves-closer-to-covid19-vaccine-trials-that-infect-volunteers-2234032
https://uk.investing.com//news/coronavirus/britain-partners-with-oxford-firm-to-assess-coronavirus-vaccine-t-cell-responses-2237611
https://uk.investing.com//news/coronavirus/exclusive-astrazeneca-us-covid19-vaccine-trial-may-resume-as-soon-as-this-week--sources-2236632
https://uk.investing.com//news/politics/fact-check-trump-and-bidens-second-and-final-presidential-debate-2238397
https://uk.investing.com//news/politics/fact-check-trump-and-bidens-second-and-final-presidential-debate-2238397#comments
https://uk.investing.com//news/stock-market-news/ftse-100-slips-as-british-airways-virus-concerns-weigh-2237693
https://uk.investing.com//news/stock-market-news/ftse-100-slips-as-british-airways-virus-concerns-weigh-2237693#comments
https://uk.investing.com//news/stock-market-news/london-stocks-track-asian-gains-on-vaccine-optimism-2235217
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-oct-21-2236855
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-oct-23-2238429
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-oct-22-2237650
https://uk.investing.com//news/world-news/panicked-europe-battens-down-against-covid-second-wave-2232407
https://uk.investing.com//news/coronavirus/astrazeneca-could-profit-from-covid19-vaccine-as-early-as-july--ft-2228380
https://uk.investing.com//news/coronavirus/eu-launches-rolling-review-of-pfizerbiontech-covid19-vaccine-2227039
https://uk.investing.com//news/coronavirus/nvidia-building-uk-supercomputer-to-boost-covid19-research-2226412
https://uk.investing.com//news/coronavirus/uk-technical-failure-in-covid19-testing-data-system-now-fixed-minister-says-2226111
https://uk.investing.com//news/coronavirus/us-signs-agreement-with-astrazeneca-to-develop-covid19-antibody-treatment-2230163
https://uk.investing.com//news/coronavirus/us-signs-agreement-with-astrazeneca-to-develop-covid19-antibody-treatment-2230163#comments
https://uk.investing.com//news/stock-market-news/as-globe-gallops-into-vaccine-trials-insurers-remain-unfazed-2230732
https://uk.investing.com//news/stock-market-news/interested-in-the-novacyt-share-price-read-this-first-2232298
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-062-2232822
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-oct-12-2230726
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-oct-8-2228669
https://uk.investing.com//news/coronavirus/eu-regulator-launches-realtime-review-of-astrazenecas-covid19-vaccine-2224443
https://uk.investing.com//news/coronavirus/exclusive-fda-widens-us-safety-inquiry-into-astrazeneca-coronavirus-vaccine--sources-2224014
https://uk.investing.com//news/coronavirus/exclusive-world-bank-seeks-board-approval-for-12-billion-coronavirus-vaccine-financing-plan-2222821
https://uk.investing.com//news/coronavirus/exclusive-world-bank-seeks-board-approval-for-12-billion-coronavirus-vaccine-financing-plan-2222821#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-resumes-vaccine-trial-in-japan-in-talks-with-us-2225065
https://uk.investing.com//news/stock-market-news/astrazeneca-still-waiting-for-fda-decision-to-resume-us-trial-2218893
https://uk.investing.com//news/stock-market-news/astrazeneca-still-waiting-for-fda-decision-to-resume-us-trial-2218893#comments
https://uk.investing.com//news/stock-market-news/canada-has-signed-deal-for-astrazeneca-vaccine-candidate--pm-2220425
https://uk.investing.com//news/stock-market-news/exclusive-astrazeneca-gets-partial-immunity-in-lowcost-eu-vaccine-deal-2219844
https://uk.investing.com//news/stock-market-news/exclusive-astrazeneca-gets-partial-immunity-in-lowcost-eu-vaccine-deal-2219844#comments
https://uk.investing.com//news/stock-market-news/ftse-100-tracks-global-markets-higher-but-set-for-weekly-losses-2219903
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-oct-1-2224068
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-sept-25-2219842
https://uk.investing.com//news/coronavirus/astrazeneca-says-covid19-vaccine-trial-in-us-still-on-hold-2215359
https://uk.investing.com//news/coronavirus/astrazenecas-trial-illnesses-may-not-be-due-to-covid19-shot--oxford-university-2212984
https://uk.investing.com//news/coronavirus/covid19-vaccine-makers-see-eu-shield-against-sideeffect-claims-2217077
https://uk.investing.com//news/coronavirus/covid19-vaccine-verdicts-loom-as-next-big-market-risk-2216691
https://uk.investing.com//news/coronavirus/in-coronavirus-vaccine-race-china-inoculates-thousands-before-trials-are-completed-2212306
https://uk.investing.com//news/stock-market-news/astrazeneca-says-tagrisso-shown-to-slow-lung-cancer-spreading-to-brain-2215283
https://uk.investing.com//news/stock-market-news/astrazenecamercks-lynparza-wins-eu-panel-recommendation-for-cancer-treatments-2215648
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-sept-16-2212307
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-sept-24-2218827
https://uk.investing.com//news/uk-stocksfactors-to-watch-on-sept-21-2215608
https://uk.investing.com//news/coronavirus/astrazeneca-shares-gain-as-coronavirus-vaccine-trials-resume-2210178
https://uk.investing.com//news/coronavirus/astrazenecas-uk-covid19-vaccine-trials-restarted-eu-medical-register-shows-2210360
https://uk.investing.com//news/coronavirus/exclusive-astrazeneca-covid19-vaccine-trial-in-us-on-hold-until-at-least-midweek--sources-2211071
https://uk.investing.com//news/coronavirus/germany-grants-biontech-curevac-745-million-to-speed-up-covid19-vaccine-work-2211746
https://uk.investing.com//news/economy/asian-shares-set-to-dip-as-investors-await-key-data-2211133
https://uk.investing.com//news/stock-market-news/dow-rallies-on-positive-vaccine-news-tech-jumps-2210988
https://uk.investing.com//news/stock-market-news/london-stocks-gain-as-astrazeneca-resumes-vaccine-trials-2210187
https://uk.investing.com//news/stock-market-news/london-stocks-gain-as-astrazeneca-resumes-vaccine-trials-2210187#comments
https://uk.investing.com//news/stock-market-news/regenerons-antibody-drug-added-to-uk-recovery-trial-of-covid-treatments-2210439
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-sept-14-2210151
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-sept-15-2211214
https://uk.investing.com//news/economic-indicators/us-weekly-jobless-claims-stuck-at-higher-levels-2208312
https://uk.investing.com//news/economy/asian-markets-set-to-come-under-pressure-after-another-down-day-on-wall-street-2206828
https://uk.investing.com//news/economy/top-5-things-to-know-in-the-market-on-wednesday-september-10th-2207109
https://uk.investing.com//news/economy/top-5-things-to-know-in-the-market-on-wednesday-september-10th-2207109#comments
https://uk.investing.com//news/economy/uk-science-adviser-other-vaccine-trials-also-likely-to-be-paused-2207529
https://uk.investing.com//news/economy/uk-science-adviser-other-vaccine-trials-also-likely-to-be-paused-2207529#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-says-should-know-if-vaccine-works-by-yearend-if-trials-resume-2208064
https://uk.investing.com//news/stock-market-news/astrazeneca-says-trials-of-covid-vaccine-resuming-2209792
https://uk.investing.com//news/stock-market-news/astrazeneca-says-trials-of-covid-vaccine-resuming-2209792#comments
https://uk.investing.com//news/stock-market-news/european-shares-inch-higher-astrazeneca-tumbles-on-halting-vaccine-trials-2206955
https://uk.investing.com//news/stock-market-news/ftse-100-gains-as-weaker-pound-offsets-astrazeneca-drag-2206959
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-sept-11-2208951
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-sept-10-2207969
https://uk.investing.com//news/coronavirus/australia-expects-to-receive-astrazenecas-covid19-vaccine-within-months-2205449
https://uk.investing.com//news/coronavirus/australias-csl-agrees-to-manufacture-two-covid19-vaccine-candidates-2205341
https://uk.investing.com//news/coronavirus/covid19-vaccine-developers-prepare-joint-safety-pledge--wsj-2204986
https://uk.investing.com//news/coronavirus/sanofi-france-chief-future-covid19-vaccine-seen-below-10-euros-2205030
https://uk.investing.com//news/coronavirus/sanofi-france-chief-sees-coronavirus-vaccine-priced-below-10-euros-2205219
https://uk.investing.com//news/economy/pause-in-astrazeneca-vaccine-trial-not-necessarily-a-setback-says-health-minister-2206915
https://uk.investing.com//news/economy/pause-in-astrazeneca-vaccine-trial-not-necessarily-a-setback-says-health-minister-2206915#comments
https://uk.investing.com//news/stock-market-news/european-stocks-seen-lower-us-tech-rout-weighs-2206920
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-sept-8-2205865
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-sept-9-2206902
https://uk.investing.com//news/stock-market-news/us-european-covid-vaccine-developers-make-pledge-to-uphold-testing-rigour-2206134
https://uk.investing.com//news/coronavirus/astrazeneca-signs-deal-with-albany-molecular-to-produce-covid19-vaccine-candidate-2203732
https://uk.investing.com//news/coronavirus/astrazeneca-starts-trial-of-covid19-antibody-treatment-2196459
https://uk.investing.com//news/coronavirus/astrazeneca-starts-trial-of-covid19-antibody-treatment-2196459#comments
https://uk.investing.com//news/coronavirus/astrazeneca-to-begin-phase-12-clinical-trials-of-coronavirus-vaccine-in-japan-2204328
https://uk.investing.com//news/coronavirus/astrazenecas-covid19-vaccine-candidate-enters-latestage-study-in-us-2201207
https://uk.investing.com//news/coronavirus/eu-pays-336-million-euros-for-doses-of-astrazenecas-potential-covid19-vaccine-2198868
https://uk.investing.com//news/coronavirus/eu-signs-contract-with-astrazeneca-on-supply-of-potential-covid19-vaccine-2198554
https://uk.investing.com//news/coronavirus/eu-signs-contract-with-astrazeneca-on-supply-of-potential-covid19-vaccine-2198554#comments
https://uk.investing.com//news/coronavirus/factbox-astrazenecas-potential-coronavirus-vaccine-2201687
https://uk.investing.com//news/coronavirus/factbox-astrazenecas-potential-coronavirus-vaccine-2201687#comments
https://uk.investing.com//news/economy/thanks-for-the-covid-vaccine-but-can-you-say-that-in-estonian-2201597
https://uk.investing.com//news/stock-market-news/stronger-pound-hits-ftse-100-after-best-august-since-2014-2201383
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-sept-1-2201323
https://uk.investing.com//news/coronavirus/astrazeneca-set-to-start-making-400-million-covid19-vaccines-for-latam-early-in-2021-2188899
https://uk.investing.com//news/coronavirus/australia-locks-in-coronavirus-vaccine-deal-as-new-cases-ease-2192488
https://uk.investing.com//news/coronavirus/australian-covid19-infections-set-to-hit-onemonth-low-2191503
https://uk.investing.com//news/coronavirus/exclusive-top-fda-official-says-would-resign-if-agency-rubberstamps-an-unproven-covid19-vaccine-2194375
https://uk.investing.com//news/coronavirus/ftse-100-tracks-asia-gains-on-virus-treatment-hopes-astrazeneca-jumps-2195593
https://uk.investing.com//news/coronavirus/ftse-100-tracks-asia-gains-on-virus-treatment-hopes-astrazeneca-jumps-2195593#comments
https://uk.investing.com//news/stock-market-news/argentine-firm-behind-astrazeneca-covid-vaccine-latam-production-sees-aprilmay-launch-2190165
https://uk.investing.com//news/stock-market-news/ftse-100-gains-on-retail-strength-stronger-sterling-weighs-on-exporters-2194474
https://uk.investing.com//news/stock-market-news/ftse-100-gains-on-retail-strength-stronger-sterling-weighs-on-exporters-2194474#comments
https://uk.investing.com//news/stock-market-news/ftse-100-gains-on-uschina-trade-optimism-2196488
https://uk.investing.com//news/stock-market-news/should-you-be-investing-money-in-pharma-stocks-2188870
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-aug-25-2196443
https://uk.investing.com//news/coronavirus/indias-wockhardt-to-make-covid19-vaccines-for-uk-2178023
https://uk.investing.com//news/coronavirus/japan-to-agree-supply-deal-soon-for-astrazenecas-coronavirus-vaccine--kyodo-2183429
https://uk.investing.com//news/coronavirus/pfizer-biontech-to-supply-120-million-doses-of-coronavirus-vaccine-to-japan-2176539
https://uk.investing.com//news/stock-market-news/day-ahead-3-things-to-watch-for-july-31-2176087
https://uk.investing.com//news/stock-market-news/exdividend-trading-trips-ftse-100-travel-firm-tui-slumps-2188199
https://uk.investing.com//news/stock-market-news/lloyds-bank-loss-hits-ftse-100-astrazeneca-gains-2175092
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-235-2175930
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-aug-10-2184834
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-aug-13-2188144
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-aug-7-2183491
https://uk.investing.com//news/coronavirus/astrazeneca-to-be-exempt-from-coronavirus-vaccine-liability-claims-in-most-countries-2175638
https://uk.investing.com//news/coronavirus/moderna-pfizer-start-decisive-covid19-vaccine-trials-eye-yearend-launches-2172361
https://uk.investing.com//news/coronavirus/moderna-vaccine-protects-against-covid19-in-monkey-study-2173551
https://uk.investing.com//news/economy/biggest-obstacle-where-can-cansino-test-its-vaccine-abroad-2175203
https://uk.investing.com//news/stock-market-news/astrazeneca-tops-forecasts-on-strong-drug-sales-outlook-unchanged-2175047
https://uk.investing.com//news/stock-market-news/astrazeneca-tops-forecasts-on-strong-drug-sales-outlook-unchanged-2175047#comments
https://uk.investing.com//news/stock-market-news/exclusive-eu-talks-with-pfizer-sanofi-jj-on-covid-vaccines-hit-snags--sources-2171875
https://uk.investing.com//news/stock-market-news/the-astrazeneca-share-price-is-reassuringly-expensive-id-buy-it-in-a-stocks-and-shares-isa-2175489
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-july-28-2172442
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-july-30-2175006
https://uk.investing.com//news/stock-market-news/us-drugmaker-earnings-heat-up-this-week-with-spotlight-on-vaccine-news-2172021
https://uk.investing.com//news/coronavirus/emergent-signs-174-million-deal-to-make-astrazenecas-potential-covid19-vaccine-2171528
https://uk.investing.com//news/coronavirus/moderna-gets-further-472-million-us-award-for-coronavirus-vaccine-development-2171115
https://uk.investing.com//news/coronavirus/us-government-engages-pfizer-to-produce-millions-of-doses-of-covid19-vaccine-2167948
https://uk.investing.com//news/coronavirus/us-government-engages-pfizer-to-produce-millions-of-doses-of-covid19-vaccine-2167948#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-to-pay-up-to-6-billion-in-new-cancer-drug-deal-with-daiichi-2171295
https://uk.investing.com//news/stock-market-news/astrazenecas-lung-disease-treatment-gets-fda-nod-2170002
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167339
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167340
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-july-22-2167701
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-july-24-2169987
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-july-27-2171271
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167330
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167331
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167332
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167334
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167335
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167336
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167337
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167338
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167341
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167342
https://uk.investing.com//news/coronavirus/additional-data-on-pfizer-and-biontechs-potential-coronavirus-vaccine-shows-promise-2165897
https://uk.investing.com//news/coronavirus/britain-signs-deals-with-pfizer-biontech-valneva-for-covid19-vaccines-2165504
https://uk.investing.com//news/stock-market-news/asian-shares-stumble-ahead-of-eu-summit-us-stimulus-talks-2165475
https://uk.investing.com//news/stock-market-news/asian-shares-stumble-ahead-of-eu-summit-us-stimulus-talks-2165475#comments
https://uk.investing.com//news/stock-market-news/oil-stocks-drag-ftse-lower-ms-hit-by-job-cuts-report-2165556
https://uk.investing.com//news/stock-market-news/stockbeat-astrazeneca-philips-synairgen-put-virus-fight-center-stage-2165623
https://uk.investing.com//news/stock-market-news/stockbeat-astrazeneca-philips-synairgen-put-virus-fight-center-stage-2165623#comments
https://uk.investing.com//news/stock-market-news/stocks--europe-lower-amid-doubts-over-summit-philips-gains-2165580
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-2167335
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-061-2164887
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-july-20-2165510
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-july-21-2166568
https://uk.investing.com//news/coronavirus/britain-nears-500-million-pound-supply-deal-for-sanofigsk-covid19-vaccine--sunday-times-2155360
https://uk.investing.com//news/coronavirus/britain-nears-500-million-pound-supply-deal-for-sanofigsk-covid19-vaccine--sunday-times-2155360#comments
https://uk.investing.com//news/coronavirus/earlystage-trial-data-on-astrazeneca-covid19-vaccine-due-july-20--lancet-2163083
https://uk.investing.com//news/coronavirus/emergent-signs-5yr-deal-backing-jj-covid19-vaccine-2155870
https://uk.investing.com//news/coronavirus/exclusive-eu-reaches-deals-with-roche-merck-for-supply-of-covid19-drugs--source-2157475
https://uk.investing.com//news/coronavirus/exclusive-eu-reaches-deals-with-roche-merck-for-supply-of-covid19-drugs--source-2157475#comments
https://uk.investing.com//news/stock-market-news/daiichi-sankyo-in-talks-with-astrazeneca-on-virus-vaccine-supply-in-japan-2149771
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-july-8-2157331
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-june-29-2150937
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-june-30-2151883
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-june-30-2151883#comments
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-june-26-2149661
https://uk.investing.com//news/world-news/vaccine-alliance-says-75-countries-keen-to-join-covax-access-facility-2162970
https://uk.investing.com//news/coronavirus/astrazeneca-covid19-vaccine-likely-to-protect-for-a-year--ceo-2142067
https://uk.investing.com//news/coronavirus/astrazeneca-taps-scottish-firm-for-tenth-covid19-vaccine-supply-deal-2148209
https://uk.investing.com//news/coronavirus/exclusive-eu-in-advanced-talks-with-johnson--johnson-on-covid19-vaccine-deal--sources-2144027
https://uk.investing.com//news/coronavirus/pig-trial-of-astrazenecas-covid19-vaccine-shows-promise-with-two-shots-2147045
https://uk.investing.com//news/coronavirus/prince-william-visits-oxford-covid19-vaccine-developers-2148587
https://uk.investing.com//news/coronavirus/singapore-scientists-to-start-human-trials-of-covid19-vaccine-in-august-2142090
https://uk.investing.com//news/coronavirus/uks-cobra-biologics-signs-astrazeneca-deal-to-supply-covid19-vaccine-2142113
https://uk.investing.com//news/economy/france-gives-its-drugs-industry-a-shot-in-the-arm-to-tackle-pandemic-2142331
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-june-25-2148737
https://uk.investing.com//news/stock-market-news/vaccine-makers-face-biggest-medical-manufacturing-feat-in-history-2148966
https://uk.investing.com//news/coronavirus/britains-astrazeneca-ramps-up-studies-for-covid19-antibody-treatments-2136944
https://uk.investing.com//news/coronavirus/britains-astrazeneca-ramps-up-studies-for-covid19-antibody-treatments-2136944#comments
https://uk.investing.com//news/coronavirus/oxford-biomedica-inks-agreement-to-boost-uk-supply-of-astrazenecas-covid19-vaccine-2135975
https://uk.investing.com//news/economy/italy-germany-france-and-netherlands-sign-contract-with-astrazeneca-for-covid-vaccine-2140739
https://uk.investing.com//news/economy/italy-germany-france-and-netherlands-sign-contract-with-astrazeneca-for-covid-vaccine-2140739#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-shares-down-2-after-report-it-approached-gilead-over-tieup-2135997
https://uk.investing.com//news/stock-market-news/londons-ftse-100-falls-as-astrazeneca-drops-on-megamerger-report-2136008
https://uk.investing.com//news/stock-market-news/londons-ftse-100-falls-as-astrazeneca-drops-on-megamerger-report-2136008#comments
https://uk.investing.com//news/stock-market-news/stocks--europe-slips-consolidating-after-gloomy-german-data-2136050
https://uk.investing.com//news/stock-market-news/stocks--europe-slips-consolidating-after-gloomy-german-data-2136050#comments
https://uk.investing.com//news/stock-market-news/uk-stocks--factors-to-watch-on-june-9-2136840
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-june-10-2137847
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-june-15-2141045
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-june-8-2135988
https://uk.investing.com//news/coronavirus/astrazeneca-eyes-over-two-billion-doses-of-potential-covid19-vaccine-after-deals-2134276
https://uk.investing.com//news/coronavirus/brazil-to-start-testing-oxford-vaccine-against-the-coronavirus-this-month-2133293
https://uk.investing.com//news/coronavirus/eu-to-use-27-billion-fund-to-buy-promising-covid19-vaccines-2133828
https://uk.investing.com//news/stock-market-news/astrazeneca-approaches-gilead-about-potential-merger--bloomberg-news-2135748
https://uk.investing.com//news/stock-market-news/astrazeneca-scores-twin-drug-approvals-alongside-vaccine-progress-2131163
https://uk.investing.com//news/stock-market-news/astrazeneca-scores-twin-drug-approvals-alongside-vaccine-progress-2131163#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-targets-two-billion-doses-poor-countries-with-covid-vaccine-deals-2134383
https://uk.investing.com//news/stock-market-news/ftse-100-retreats-after-rallying-on-recovery-optimism-2133775
https://uk.investing.com//news/stock-market-news/london-stocks-jump-as-retailers-set-to-reopen-from-shutdown-2130865
https://uk.investing.com//news/stock-market-news/london-stocks-jump-as-retailers-set-to-reopen-from-shutdown-2130865#comments
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-june-5-2134706
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-june-8-2135962
https://uk.investing.com//news/coronavirus/how-one-indian-company-could-be-worlds-door-to-a-covid19-vaccine-2125675
https://uk.investing.com//news/coronavirus/oxford-biomedica-inks-deal-to-make-astrazenecas-potential-covid19-vaccine-2128964
https://uk.investing.com//news/coronavirus/project-leader-oxfords-covid19-vaccine-trial-has-50-chance-of-success--telegraph-2126063
https://uk.investing.com//news/stock-market-news/oxford-biomedica-hires-french-pharma-veteran-after-signing-vaccine-deal-2130853
https://uk.investing.com//news/stock-market-news/recovery-hopes-power-uk-stocks-easyjet-jumps-2128718
https://uk.investing.com//news/stock-market-news/recovery-hopes-power-uk-stocks-easyjet-jumps-2128718#comments
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-123-2127339
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-134-2128318
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-may-28-2128661
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-may-29-2129625
https://uk.investing.com//news/stock-market-news/uk-stocksfactors-to-watch-on-may-29-2129625#comments
https://uk.investing.com//news/stock-market-news/update-1uk-stocksfactors-to-watch-on-may-29-2129688
https://uk.investing.com//news/coronavirus/astrazeneca-to-produce-oxford-universitys-potential-covid19-vaccine-2108103
https://uk.investing.com//news/coronavirus/keenlywatched-covid19-vaccine-wont-be-expensive-developer-says-2120374
https://uk.investing.com//news/coronavirus/london-stocks-dip-as-coronavirus-damage-mounts-2112566
https://uk.investing.com//news/coronavirus/pfizer-aims-for-1020-million-doses-of-coronavirus-vaccine-by-end2020-for-emergency-use-2108694
https://uk.investing.com//news/coronavirus/take-five-coronavirus-vaccine-race-is-on-2125552
https://uk.investing.com//news/economy/top-5-things-to-know-in-the-market-on-thursday-may-21st-2124376
https://uk.investing.com//news/economy/top-5-things-to-know-in-the-market-on-thursday-may-21st-2124376#comments
https://uk.investing.com//news/stock-market-news/astrazeneca-diabetes-drug-gets-us-nod-to-treat-heart-failure-2112601
https://uk.investing.com//news/stock-market-news/astrazeneca-in-talks-with-other-governments-to-replicate-uk-vaccine-deal-2121912
https://uk.investing.com//news/stock-market-news/here-are-my-top-3-investing-ideas-of-the-decade-for-navigating-the-ftse-100-stock-index-2121300
https://uk.investing.com//news/stock-market-news/stocks--europe-edges-lower-ftse-100-outperforms-2112627
https://uk.investing.com//news/coronavirus/astrazeneca-to-start-calquence-in-covid19-trial-2095229
https://uk.investing.com//news/coronavirus/astrazeneca-trials-farxiga-as-potential-treatment-for-covid19-patients-2102667
https://uk.investing.com//news/stock-market-news/astrazeneca-beats-firstquarter-profit-estimates-retains-2020-forecast-2106965
https://uk.investing.com//news/stock-market-news/astrazeneca-rbs-results-drag-down-ftse-100-2052100
https://uk.investing.com//news/stock-market-news/astrazenecas-ceo-reaffirms-2021-targets-2052274
https://uk.investing.com//news/stock-market-news/ftse-100-edges-lower-amid-earnings-jitters-2099570
https://uk.investing.com//news/stock-market-news/gsk-firstquarter-profit-beats-on-steady-demand-for-shingrix-2107229
https://uk.investing.com//news/stock-market-news/london-stocks-gain-as-global-economies-reopen-stanchart-jumps-2107019
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-058-2052650
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-086-2095895
https://uk.investing.com//news/economy/top-5-things-to-know-in-the-market-on-friday-february-14th-2052237
https://uk.investing.com//news/economy/top-5-things-to-know-in-the-market-on-friday-february-14th-2052237#comments
https://uk.investing.com//news/stock-market-news/abbvieallergan-63-billion-deal-aided-by-nestle-astrazeneca-buys-2038380
https://uk.investing.com//news/stock-market-news/astrazeneca-says-2020-sales-growth-to-take-coronavirus-hit-2052064
https://uk.investing.com//news/stock-market-news/centrica-barclays-weigh-down-ftse-100-2051109
https://uk.investing.com//news/stock-market-news/defensive-stocks-buoy-ftse-100-before-uschina-trade-deal-2031182
https://uk.investing.com//news/stock-market-news/defensive-stocks-buoy-ftse-100-before-uschina-trade-deal-2031182#comments
https://uk.investing.com//news/stock-market-news/drugmakers-slash-prices-to-be-eligible-for-chinas-bulkbuy-program-2033620
https://uk.investing.com//news/stock-market-news/japan-us-lead-surveys-corporate-climate-change-action-a-list-2034006
https://uk.investing.com//news/stock-market-news/jpmorgan-to-buy-paris-building-to-bring-euro-teams-from-london-2033818
https://uk.investing.com//news/stock-market-news/roche-wins-approval-for-cancer-drug-kadcyla-in-fastgrowing-china-market-2035877
https://uk.investing.com//news/stock-market-news/stocks--europe-heads-lower-rbs-renault-astrazeneca-weigh-2052116
https://uk.investing.com//news/forex-news/premarket-london-william-hill-beats-profit-expectations-2029433
https://uk.investing.com//news/stock-market-news/astrazenecamerck-lynparza-wins-approval-in-china-for-ovarian-cancer-treatment-2009413
https://uk.investing.com//news/stock-market-news/astrazenecamercks-lynparza-gets-fda-okay-to-treat-pancreatic-cancer-2022427
https://uk.investing.com//news/stock-market-news/ftse-100-dips-on-yearend-profit-taking-stronger-pound-2022971
https://uk.investing.com//news/stock-market-news/ftse-extends-slide-as-trumps-tariff-salvo-dents-sentiment-2007804
https://uk.investing.com//news/stock-market-news/ftse-extends-slide-as-trumps-tariff-salvo-dents-sentiment-2007804#comments
https://uk.investing.com//news/stock-market-news/ftse-falls-for-fifth-day-on-trump-trade-rhetoric-firm-pound-2008608
https://uk.investing.com//news/stock-market-news/premarket-london-ds-smith-posts-strong-h1-ig-revenue-flat-2009392
https://uk.investing.com//news/stock-market-news/premarket-london-shell-raises-oil-output-sees-charges-forecast-2019147
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-048-2018851
https://uk.investing.com//news/stock-market-news/uk-stock-rally-halts-as-traders-pocket-profits-2022442
https://uk.investing.com//news/stock-market-news/astrazeneca-shares-rise-on-early-us-approval-for-leukaemia-drug-2002847
https://uk.investing.com//news/stock-market-news/astrazenecas-imfinzi-gets-fda-priority-review-for-small-cell-lung-cancer-2006250
https://uk.investing.com//news/stock-market-news/britains-astrazeneca-launches-1-billion-china-investment-fund-with-cicc-1992036
https://uk.investing.com//news/stock-market-news/ftse-slips-on-exdiv-trading-uschina-trade-doubts-2005931
https://uk.investing.com//news/stock-market-news/premarket-london-ba-parent-cuts-growth-estimates-astrazeneca-success-1994278
https://uk.investing.com//news/stock-market-news/premarket-london-boohoo-reports-record-black-friday-ferguson-solid-2007781
https://uk.investing.com//news/stock-market-news/premarket-london-talk-talk-swings-to-1h-profit-888-defiant-1998659
https://uk.investing.com//news/stock-market-news/rising-hong-kong-tensions-drag-asiaexposed-uk-stocks-1995494
https://uk.investing.com//news/stock-market-news/uk-shares-bounce-back-after-tradedriven-losses-2002586
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-039-1988353
https://uk.investing.com//news/forex-news/newsbreak-astrazenecas-diabetes--drug-farxiga-gets-us-approval-1981809
https://uk.investing.com//news/stock-market-news/astrazeneca-raises-sales-forecast-after-surge-in-cancer-drugs-1984507
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-european-rights-for-schizophrenia-drug-to-cheplapharm-1987915
https://uk.investing.com//news/stock-market-news/ftse-100-on-track-for-fourth-session-of-gains-1984363
https://uk.investing.com//news/stock-market-news/premarket-london-astrazeneca-raises-guidance-ppi-drives-rbs-to-loss-1984325
https://uk.investing.com//news/stock-market-news/stockbeat-dax-hits-17month-high-on-hope-that-germany-has-hit-bottom-1984451
https://uk.investing.com//news/stock-market-news/stockbeat-dax-hits-17month-high-on-hope-that-germany-has-hit-bottom-1984451#comments
https://uk.investing.com//news/stock-market-news/the-elephant-in-the-room-with-astrazenecas-latest-update-1986227
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-105-1984868
https://uk.investing.com//news/stock-market-news/us-fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-1981828
https://uk.investing.com//news/stock-market-news/what-next-for-the-astrazeneca-share-price-1987373
https://uk.investing.com//news/economic-indicators/jd-sports-leads-ftse-100-higher-rate-cut-hopes-support-1959515
https://uk.investing.com//news/politics/with-a-backup-to-the-backup-insulin-makers-say-theyre-primed-for-brexit-1963697
https://uk.investing.com//news/stock-market-news/astrazeneca-strengthens-lynparza-push-with-prostate-cancer-data-1972711
https://uk.investing.com//news/stock-market-news/factbox--how-are-businesses-preparing-for-a-nodeal-brexit-1979126
https://uk.investing.com//news/stock-market-news/ftse-100-slips-as-pound-recovers-diageo-slides-1961790
https://uk.investing.com//news/stock-market-news/ftse-gains-as-thomas-cook-collapse-buoys-bluechip-rivals-1967572
https://uk.investing.com//news/stock-market-news/ftse-gains-as-thomas-cook-collapse-buoys-bluechip-rivals-1967572#comments
https://uk.investing.com//news/stock-market-news/londons-bluechip-index-gains-ground-sirius-minerals-sinks-1963709
https://uk.investing.com//news/stock-market-news/londons-bluechip-index-gains-ground-sirius-minerals-sinks-1963709#comments
https://uk.investing.com//news/stock-market-news/uk-shares-climb-higher-ferguson-advances-1973151
https://uk.investing.com//news/stock-market-news/uk-shares-climb-higher-ferguson-advances-1973151#comments
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-064-1966187
https://uk.investing.com//news/stock-market-news/weak-us-euro-zone-data-push-european-shares-lower-1973694
https://uk.investing.com//news/economy/miners-help-ftse-100-override-trade-worries-1953652
https://uk.investing.com//news/stock-market-news/astrazeneca-lupus-drug-meets-main-goal-in-study-1951715
https://uk.investing.com//news/stock-market-news/astrazeneca-says-us-fda-grants-fast-track-status-for-diabetes-drug-farxiga-1949931
https://uk.investing.com//news/stock-market-news/astrazenecas-tagrisso-gets-china-ok-for-type-of-lung-cancer-1955022
https://uk.investing.com//news/stock-market-news/encouraging-china-trade-comments-weaker-pound-lift-ftse-100-1951738
https://uk.investing.com//news/stock-market-news/ftse-100-little-changed-as-several-stocks-trade-exdividend-industrials-rise-1956064
https://uk.investing.com//news/stock-market-news/london-leads-european-markets-lower-as-investors-play-waiting-game-1949955
https://uk.investing.com//news/stock-market-news/steady-pound-growth-worries-pressure-ftse-100-galliford-jumps-1958965
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-111-1953890
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-069-1958588
https://uk.investing.com//news/economy/glencore-fall-hits-mining-stocks-as-ftse-steadies-1935606
https://uk.investing.com//news/stock-market-news/astrazeneca-quarterly-product-sales-beat-on-cancer-drug-strength-1924889
https://uk.investing.com//news/stock-market-news/astrazenecas-farxiga-meets-main-goal-of-heart-failure-study-1945453
https://uk.investing.com//news/stock-market-news/astrazenecas-imfinzi-misses-main-goal-of-advanced-lung-cancer-study-1946341
https://uk.investing.com//news/stock-market-news/european-shares-rise-for-third-straight-session-1945457
https://uk.investing.com//news/stock-market-news/ftse-100-flat-after-mixed-corporate-earnings-1924927
https://uk.investing.com//news/stock-market-news/gsk-forecasts-smaller-hit-to-fullyear-profit-after-second-quarter-beat-1923817
https://uk.investing.com//news/stock-market-news/should-i-sell-my-shares-if-a-recession-is-imminent-1948830
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-019-1925693
https://uk.investing.com//news/stock-market-news/weak-pound-astrazeneca-push-ftse-higher-1945464
https://uk.investing.com//news/economy-news/top-5-things-to-know-in-the-market-on-thursday-1446697
https://uk.investing.com//news/stock-market-news/as-steep-patent-cliff-looms-shionogi-moves-to-develop-its-own-us-sales-staff-1918220
https://uk.investing.com//news/stock-market-news/exclusive-woodford-biotech-stakes-first-off-block-in-asset-sale--source-1918802
https://uk.investing.com//news/stock-market-news/ftse-100-hits-10month-high-on-weaker-sterling-telford-soars-1909535
https://uk.investing.com//news/stock-market-news/ftse-100-set-to-snap-sixday-losing-streak-thomas-cook-plummets-1915366
https://uk.investing.com//news/stock-market-news/gsk-names-hsbcs-symonds-as-nonexec-chairman-1923666
https://uk.investing.com//news/stock-market-news/heres-a-dirt-cheap-way-of-creating-a-second-income-stream-through-the-stock-market-1432647
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-034-1447169
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-058-1477823
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-143-1517876
https://uk.investing.com//news/stock-market-news/british-shares-on-track-for-best-week-since-september-housebuilders-bounce-1422360
https://uk.investing.com//news/stock-market-news/ftse-breaks-threeday-losing-streak-vodafone-hits-multiyear-lows-1431799
https://uk.investing.com//news/stock-market-news/italy-drugmaker-zambon-ready-to-splash-out-in-us-china-push-1431073
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-065-1431204
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-085-1432273
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-040-1427987
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-050-1423730
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-051-1430029
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-039-1422651
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-096-1423744
https://uk.investing.com//news/stock-market-news/astrazeneca-picks-baselga-to-lead-oncology-rd-in-growth-plan-1418928
https://uk.investing.com//news/stock-market-news/ftse-flat-ahead-of-trade-talks-dunelm-lifts-midcaps-1418636
https://uk.investing.com//news/stock-market-news/oil-drives-uk-stocks-up-as-relief-bounce-spills-over-from-us-1413641
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-032-1419104
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-089-1421141
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-122-1420238
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-088-1416880
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-214-1410439
https://uk.investing.com//news/stock-market-news/uk-markets-rise-as-the-curtain-falls-on-a-dim-2018-1414670
https://uk.investing.com//news/stock-market-news/uk-stocks-climb-wall-street-ladder-1412958
https://uk.investing.com//news/economy-news/pharma-industry-returns-on-rd-investment-hit-9year-low-1408920
https://uk.investing.com//news/stock-market-news/astrazenecas-imfinzi-fails-to-meet-main-goals-in-head-and-neck-cancer-study-1401087
https://uk.investing.com//news/stock-market-news/astrazenecas-ovarian-cancer-and-anaemia-treatments-meet-goals-in-latestage-studies-1409953
https://uk.investing.com//news/stock-market-news/biocartis-partners-with-astrazeneca-on-lung-cancer-diagnostics-1393602
https://uk.investing.com//news/stock-market-news/ftse-100-tumbles-as-weak-chinese-data-dents-markets-1406011
https://uk.investing.com//news/stock-market-news/gsk-to-buy-cancer-drugmaker-tesaro-for-51-billion-1396457
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-075-1389405
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-141-1390726
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-197-1404630
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-153-1398224
https://uk.investing.com//news/stock-market-news/astrazeneca-returns-to-sales-growth-led-by-cancer-medicines-1373277
https://uk.investing.com//news/stock-market-news/ftse-outperforms-european-peers-as-brexit-angst-sinks-sterling-1377046
https://uk.investing.com//news/stock-market-news/ftse-supported-by-financials-astrazeneca-1373358
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-065-1383565
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-148-1387972
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-012-1374126
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-029-1370547
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-104-1377654
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-173-1386697
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-044-1374155
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-older-asthma-rhinitis-drugs-for-350-million-1369775
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-some-rights-to-nexium-vimovo-to-grunenthal-1360905
https://uk.investing.com//news/stock-market-news/astrazeneca-to-buy-98-percent-stake-in-frances-innate-pharma-1352344
https://uk.investing.com//news/stock-market-news/micro-focus-leads-ftse-higher-in-choppy-trade-1368346
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-030-1356493
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-046-1365459
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-080-1368912
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-015-1368941
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-019-1365485
https://uk.investing.com//news/stock-market-news/why-i-think-it-might-finally-be-time-to-buy-ftse-100-dividend-stock-glaxosmithkline-1363574
https://uk.investing.com//news/politics-news/astrazeneca-halts-uk-investments-due-to-brexit-uncertainties--le-monde-1343686
https://uk.investing.com//news/stock-market-news/pfizer-ceo-ian-read-to-step-down-next-year-1332128
https://uk.investing.com//news/stock-market-news/roche-posts-modest-third-quarter-sales-beat-as-new-drugs-offset-biosimilar-hit-1346077
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-010-1326555
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-010-1328147
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-031-1332684
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-109-1329560
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-038-1346932
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-084-1330834
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-090-1342012
https://uk.investing.com//news/politics-news/french-drugmakers-urge-brexit-negotiators-to-safeguard-supply-chain-1307223
https://uk.investing.com//news/stock-market-news/astrazeneca-gets-fda-breakthrough-therapy-label-for-asthma-treatment-1307968
https://uk.investing.com//news/stock-market-news/astrazeneca-plots-china-robot-offensive-to-counter-price-cuts-1319833
https://uk.investing.com//news/stock-market-news/astrazeneca-switches-contractor-as-new-headquarter-delayed-again-1292654
https://uk.investing.com//news/stock-market-news/pfizer-bets-on-biotech-flu-vaccine-in-425-million-biontech-alliance-1286782
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-019-1314675
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-051-1290208
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-111-1287551
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-010-1313152
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-031-1283104
https://uk.investing.com//news/politics-news/sanofi-has-been-stockpiling-drugs-for-nodeal-brexit--wsj-1267712
https://uk.investing.com//news/stock-market-news/astrazenecas-key-lung-cancer-drug-wins-european-panel-thumbsup-1262958
https://uk.investing.com//news/stock-market-news/ftse-extends-gains-as-oil-stocks-power-ahead-housebuilders-fall-1277198
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-011-1273978
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-028-1267175
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-053-1279710
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-063-1275564
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-071-1276169
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-088-1281210
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-011-1261592
https://uk.investing.com//news/politics-news/astrazeneca-to-stockpile-drugs-as-brexit-safety-net-1250163
https://uk.investing.com//news/politics-news/eu-drug-regulators-step-up-work-to-prepare-for-no-deal-brexit-1253813
https://uk.investing.com//news/stock-market-news/european-shares-rise-as-useu-trade-breakthrough-spurs-carmakers-1260634
https://uk.investing.com//news/stock-market-news/ftse-100-recovers-driven-by-defensives-as-trade-nerves-ebb-1243683
https://uk.investing.com//news/stock-market-news/gsks-new-rd-head-bets-on-genetics-with-300-million-23andme-deal-1258822
https://uk.investing.com//news/stock-market-news/hitting-cancer-early--astrazenecas-bid-to-outmanoeuvre-rivals-1237658
https://uk.investing.com//news/stock-market-news/shell-slide-weighs-on-ftse-as-earnings-in-focus-1260709
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-098-1261544
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-100-1244438
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-079-1244457
https://uk.investing.com//news/politics-news/eu-industry-lobby-adds-to-pressure-on-britain-over-brexit-talks-1191553
https://uk.investing.com//news/stock-market-news/astrazeneca-cancer-drug-hits-second-goal-by-extending-survival-1186690
https://uk.investing.com//news/stock-market-news/astrazeneca-drug-fasenra-fails-to-achieve-main-goal-in-copd-trial-1190744
https://uk.investing.com//news/stock-market-news/emirates-starts-london-stansted-flights-as-rival-airports-near-capacity-1208604
https://uk.investing.com//news/stock-market-news/ftse-rebounds-kingfisher-jumps-as-homebase-changes-hands-1186783
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-029-1180799
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-126-1200957
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-030-1202354
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-138-1184152
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-171-1224217
https://uk.investing.com//news/politics-news/mps-call-for-postbrexit-pharmaceutical-deal-with-eu-1176318
https://uk.investing.com//news/stock-market-news/astrazeneca-hit-by-falling-crestor-sales-higher-costs-1178131
https://uk.investing.com//news/stock-market-news/astrazeneca-potassium-drug-finally-approved-threatening-vifor-1180234
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-rights-for-seroquel-to-luye-pharma-for-538-million-1162883
https://uk.investing.com//news/stock-market-news/astrazeneca-to-raise-stake-in-circassia-to-up-to-199-percent-1140263
https://uk.investing.com//news/stock-market-news/bp-oil-prices-keep-ftse-afloat-1152095
https://uk.investing.com//news/stock-market-news/gsk-bets-on-lift-from-new-lung-drugs-ahead-of-advairs-last-gasp-1177974
https://uk.investing.com//news/stock-market-news/shires-mega-deal-fails-to-lift-ftse-amid-global-gloom-1142725
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-016-1178892
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-010-1178913
https://uk.investing.com//news/stock-market-news/compugen-astrazeneca-unit-in-cancer-drug-development-deal-1107229
https://uk.investing.com//news/stock-market-news/experts-query-case-for-glaxosmithklines-new-3in1-lung-drug-1133299
https://uk.investing.com//news/stock-market-news/industry-fears-disruption-as-eu-excludes-uk-from-drug-approvals-1132280
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-013-1102622
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-124-1130541
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-003-1128516
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-118-1083194
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-166-1085413
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-173-1109632
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-219-1090707
https://uk.investing.com//news/stock-market-news/astrazeneca-sees-pivotal-lung-cancer-trial-results-later-in-2018-1075109
https://uk.investing.com//news/stock-market-news/astrazenecas-immunotherapy-drug-wins-key-lung-cancer-approval-1044342
https://uk.investing.com//news/stock-market-news/big-pharma-big-data--why-drugmakers-want-your-health-records-1060631
https://uk.investing.com//news/stock-market-news/gains-for-south-africaexposed-stocks-cyclicals-soothe-ftse-100-1038392
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-026-1073706
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-045-1079711
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-069-1039740
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-078-1067867
https://uk.investing.com//news/stock-market-news/us-fda-approves-astrazenecas-immunotherapy-for-lung-cancer-1043159
https://uk.investing.com//news/stock-market-news/us-health-officials-reverse-stance-on-astrazenecas-flu-vaccine-1048757
https://uk.investing.com//news/stock-market-news/astrazeneca-flags-return-to-drug-sales-growth-in-2018-1012061
https://uk.investing.com//news/stock-market-news/ftse-100-dips-as-strong-pound-dampens-dollarearners-1032837
https://uk.investing.com//news/stock-market-news/ftse-100-heads-for-worst-week-in-six-months-as-results-drag-1012179
https://uk.investing.com//news/stock-market-news/ftse-dips-ahead-of-boe-meeting-but-drugmakers-give-support-1023908
https://uk.investing.com//news/stock-market-news/gsk-cautious-on-2018-as-drug-competition-looms-after-fourthquarter-beats-1021046
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-106-1013420
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-129-1028293
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-202-1025519
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-062-1013437
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-146-1016463
https://uk.investing.com//news/stock-market-news/astrazeneca-is-sued-by-array-biopharma-over-cancer-drug-royalties-1011610
https://uk.investing.com//news/stock-market-news/astrazeneca-links-with-alibaba-and-tencent-in-china-push-1012291
https://uk.investing.com//news/stock-market-news/astrazenecas-inhaler-for-lung-disease-shows-improved-function-in-late-stage-trail-998281
https://uk.investing.com//news/stock-market-news/at-astrazeneca-fewer-drug-projects-bring-big-productivity-jump-984564
https://uk.investing.com//news/stock-market-news/deutsche-bank-drags-european-shares-into-worst-week-since-august-1012111
https://uk.investing.com//news/stock-market-news/new-drug-approvals-hit-21year-high-in-2017-954222
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-101-959578
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-018-969510
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-064-952155
https://uk.investing.com//news/stock-market-news/uk-stocks-end-two-days-of-currencydriven-declines-998361
https://uk.investing.com//news/politics-news/brexit-gets-real-for-drugmakers-as-regulator-moves-to-amsterdam-749419
https://uk.investing.com//news/stock-market-news/ftse-stuck-at-sevenweek-lows-as-cyclicals-shire-declines-745186
https://uk.investing.com//news/stock-market-news/over-20-percent-of-uk-companies-faced-shareholder-revolt--pay-study-935547
https://uk.investing.com//news/stock-market-news/roche-to-seize-leapfrog-opportunity-in-lung-cancer-847941
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-009-736557
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-021-803843
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-041-950386
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-073-952099
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-007-950424
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-094-803908
https://uk.investing.com//news/stock-market-news/astrazeneca-thirdquarter-sales-weak-as-it-waits-for-medicine-to-work-724059
https://uk.investing.com//news/stock-market-news/european-shares-open-a-touch-lower-as-more-thirdquarter-earnings-pour-in-724070
https://uk.investing.com//news/stock-market-news/former-gsk-boss-to-lead-new-uk-accelerated-drug-access-scheme-650695
https://uk.investing.com//news/stock-market-news/ftse-rises-as-sterlings-decline-boosts-exporters-727921
https://uk.investing.com//news/stock-market-news/gsk-nabs-calico-scientist-barron-as-new-rd-head-vallance-quits-723895
https://uk.investing.com//news/stock-market-news/gsks-rd-head-to-leave-for-top-uk-government-job--source-650732
https://uk.investing.com//news/stock-market-news/short-seller-kerrisdale-targets-woodfordbacked-prothena-723921
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-012-733086
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-035-723701
https://uk.investing.com//news/stock-market-news/uk-shares-lower-at-close-of-trade-investingcom-united-kingdom-100-down-025-729638
https://uk.investing.com//news/politics-news/pharma-and-medtech-industries-prepare-for-hard-brexit-518490
https://uk.investing.com//news/stock-market-news/astrazeneca-among-backers-as-swiss-cancer-biotech-raises-200-million-519987
https://uk.investing.com//news/stock-market-news/astrazeneca-asthma-drug-tralokinumab-disappoints-again-650228
https://uk.investing.com//news/stock-market-news/astrazeneca-licenses-genetic-disease-drug-to-mereo-biopharma-649745
https://uk.investing.com//news/stock-market-news/astrazeneca-plans-new-pivotal-lung-cancer-trial-with-incyte-649996
https://uk.investing.com//news/stock-market-news/china-biotechs-coming-out-party-masks-long-road-ahead-519163
https://uk.investing.com//news/stock-market-news/ftse-scales-twomonth-peak-516743
https://uk.investing.com//news/stock-market-news/merck-posts-quarterly-loss-versus-yearago-profit-521046
https://uk.investing.com//news/stock-market-news/pfizer-consumer-units-sales-fall-ahead-of-divestiture-call-650142
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-004-650625
https://uk.investing.com//news/politics-news/drugs-firm-astrazeneca-wants-threeyear-brexit-transition-515906
https://uk.investing.com//news/politics-news/tell-us-how-brexit-will-work-british-companies-demand-515920
https://uk.investing.com//news/stock-market-news/aspen-to-buy-remaining-astrazeneca-anaesthetic-rights-for-up-to-766-million-512669
https://uk.investing.com//news/stock-market-news/drug-industry-fails-to-win-judicial-review-of-new-uk-cost-curbs-516367
https://uk.investing.com//news/stock-market-news/gates-foundation-invests-40-million-in-uk-immunotherapy-company-513297
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-010-513619
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-017-515950
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-021-514696
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-028-514325
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-068-514328
https://uk.investing.com//news/stock-market-news/astrazeneca-rebuilds-cancer-drug-hopes-with-new-lung-data-511749
https://uk.investing.com//news/stock-market-news/insurers-lead-european-shares-higher-after-hurricane-irma-downgrade-511951
https://uk.investing.com//news/stock-market-news/mercks-immunotherapy-chemo-mix-shows-extended-lung-cancer-gains-511522
https://uk.investing.com//news/stock-market-news/new-astrazeneca-amgen-biotech-drug-offers-broad-asthma-relief-511258
https://uk.investing.com//news/stock-market-news/sterling-high-hurts-ftse-100-512448
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-076-511455
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-077-510386
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-128-512041
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-037-511183
https://uk.investing.com//news/stock-market-news/uk-shares-higher-at-close-of-trade-investingcom-united-kingdom-100-up-067-511460
https://uk.investing.com//news/stock-market-news/astrazeneca-sought-to-buy-japans-daiichi-sankyo-last-year--report-510015
https://uk.investing.com//news/stock-market-news/astrazeneca-taps-ai-for-drug-discovery-in-deal-with-berg-509518
https://uk.investing.com//news/stock-market-news/cyclicals-housebuilders-dent-ftse-coca-cola-hbc-rises-506695
https://uk.investing.com//news/stock-market-news/daiichi-sankyo-denies-receiving-takeover-bid-from-astrazeneca-510143
https://uk.investing.com//news/stock-market-news/fda-approves-expanded-use-of-astrazeneca-ovarian-cancer-drug-507900
https://uk.investing.com//news/stock-market-news/ftse-100-flat-as-wpp-sinks-508670
https://uk.investing.com//news/stock-market-news/income-investors-run-for-cover-as-dependable-uk-dividends-in-jeopardy-506518
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade-omx-stockholm-30-up-099-509915
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-078-507852
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade-omx-stockholm-30-down-105-506774
https://uk.investing.com//news/stock-market-news/astrazeneca-drug-sales-slide-as-key-cancer-drug-news-awaited-504358
https://uk.investing.com//news/stock-market-news/astrazeneca-investor-woodford-says-share-fall-on-mystic-results-not-justified-504666
https://uk.investing.com//news/stock-market-news/astrazeneca-pain-weighs-on-ftse,-diageo-makes-merry-after-results-504410
https://uk.investing.com//news/stock-market-news/bayer-cuts-profit-forecast-after-consumer-health-headache-504450
https://uk.investing.com//news/stock-market-news/dividends-a-worry-at-drugmakers-astra,-gsk-after-dramatic-week-504682
https://uk.investing.com//news/stock-market-news/ftse-heads-for-weekly-loss-as-italy-takes-toll-on-bt-504669
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.62-504526
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.82-504751
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-0.08-504532
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-1.03-504755
https://uk.investing.com//news/economy-news/top-5-things-to-know-in-the-market-on-thursday-504431
https://uk.investing.com//news/stock-market-news/astrazeneca-offers-no-comment-after-report-saying-ceo-staying-502093
https://uk.investing.com//news/stock-market-news/astrazeneca-shares-fall-for-a-second-day-over-ceo-uncertainty-501945
https://uk.investing.com//news/stock-market-news/astrazeneca-slump-dominates-european-open-on-busy-earnings-day-504389
https://uk.investing.com//news/stock-market-news/ftse-falters,-but-set-for-weekly-gain;-carillion-sees-relief-501963
https://uk.investing.com//news/stock-market-news/glaxosmithkline's-new-boss-streamlines-drug-research-504174
https://uk.investing.com//news/stock-market-news/glaxosmithkline's-new-ceo-prepares-to-trim-drug-pipeline-503341
https://uk.investing.com//news/stock-market-news/global-stocks-mostly-higher-as-fed-holds,-heavy-earnings-flow-504406
https://uk.investing.com//news/stock-market-news/gsk-hires-ex-wal-mart-executive-to-transform-tech-operations-503941
https://uk.investing.com//news/stock-market-news/u.k.-stocks-edge-lower-after-earnings-spate,-astrazeneca-plunges-504428
https://uk.investing.com//news/politics-news/british-ministers-want-postbrexit-drug-regulation-deal-with-eu-499704
https://uk.investing.com//news/stock-market-news/astrazeneca's-ceo-soriot-to-join-israeli-drugs-company-teva---report-501658
https://uk.investing.com//news/stock-market-news/astrazeneca,-chi-med-take-kidney-cancer-drug-into-final-testing-498899
https://uk.investing.com//news/stock-market-news/astrazeneca-holds-ftse-back,-carillion-loses-last-'buy'-rating-501712
https://uk.investing.com//news/stock-market-news/ftse-down-in-the-dumps-as-defensives,-pearson-and-m-amp;s-fall-501228
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.20-501310
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.38-500416
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.49-501820
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-0.08-501825
https://uk.investing.com//news/stock-market-news/u.k.-stocks-edge-up-as-pound-firms-501735
https://uk.investing.com//news/politics-news/ftse-haunted-by-uncertainty-one-year-after-brexit-vote-497792
https://uk.investing.com//news/stock-market-news/astrazeneca-cancer-drug-trial-prompts-investors-to-take-options-cover-498536
https://uk.investing.com//news/stock-market-news/ftse-wallows-at-one-week-low-as-energy-weighs;-imagination-tech-rockets-497521
https://uk.investing.com//news/stock-market-news/gsk-to-get-new-pharma-head-in-september,-after-astrazeneca-tussle-496810
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.15-498751
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.22-497609
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.11-498285
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.35-497078
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.91-498513
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-0.76-497081
https://uk.investing.com//news/stock-market-news/financials-lift-ftse-as-markets-brace-for-election-178172
https://uk.investing.com//news/stock-market-news/ftse-edge-up-helped-by-m-amp;s-but-miners-weigh-175317
https://uk.investing.com//news/stock-market-news/ftse-heads-for-third-straight-week-of-gains-as-astrazeneca-rises-172840
https://uk.investing.com//news/stock-market-news/how-astrazeneca-cancer-drug-forecasts-are-set-to-rise-173325
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.27-172949
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.60-179723
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.67-179011
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.86-174465
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.55-179992
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-0.62-172953
https://uk.investing.com//news/economy-news/circassia-gives-up-on-allergy-after-house-dust-mite-study-fails-167868
https://uk.investing.com//news/stock-market-news/astrazeneca's-durvalumab-shown-in-trial-to-reduce-risk-of-death-from-lung-cancer-172791
https://uk.investing.com//news/stock-market-news/astrazeneca-boosts-early-respiratory-medicine-with-pieris-deal-170764
https://uk.investing.com//news/stock-market-news/astrazeneca-moving-costs-rise-as-new-headquarter-nears-completion-169280
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.83-172069
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-2.29-169081
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.21-172349
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-0.58-172077
https://uk.investing.com//news/stock-market-news/u.k.-stocks-edge-higher,-pound-lower-as-boe-holds-172827
https://uk.investing.com//news/stock-market-news/weak-sterling-boosts-glaxsmithkline-as-new-ceo-takes-over-169521
https://uk.investing.com//news/politics-news/brexit-doesnt-mean-tight-immigration-minister-tells-scientists-165554
https://uk.investing.com//news/stock-market-news/astrazeneca-wins-approval-for-lung-cancer-pill-in-china-163618
https://uk.investing.com//news/stock-market-news/ftse-hits-one-month-low-as-miners,-babcock-slide-163660
https://uk.investing.com//news/stock-market-news/gsk-and-regeneron-to-mine-gene-data-from-500,000-britons-162871
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.18-166652
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.35-166060
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.17-163062
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.33-163756
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.50-162794
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-0.17-165804
https://uk.investing.com//news/stock-market-news/astrazeneca's-lynparza-meets-main-goal-in-breast-cancer-study-156057
https://uk.investing.com//news/stock-market-news/astrazeneca-ovarian-cancer-drug-slows-disease-markedly-in-study-161041
https://uk.investing.com//news/stock-market-news/ftse-set-for-week-of-modest-gains,-pharmas-lead-156016
https://uk.investing.com//news/stock-market-news/ftse-slips-from-record-high-as-banks,-oil-drag-162161
https://uk.investing.com//news/stock-market-news/miners-support-ftse,-m-amp;a-sends-mid-caps-to-record-high-160695
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.16-159903
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.39-157299
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.35-158480
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.36-156100
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.68-158789
https://uk.investing.com//news/stock-market-news/european-shares-set-for-second-weekly-gain;-allianz-rallies-after-update-155976
https://uk.investing.com//news/stock-market-news/ftse-retreats-from-one-month-peak,-commodity-linked-stocks-weigh-155757
https://uk.investing.com//news/stock-market-news/new-glaxosmithkline-ceo-prepares-for-r-d-choices,-potential-deals-153595
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.13-153872
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.15-155860
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.27-155601
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.53-154388
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.54-153648
https://uk.investing.com//news/stock-market-news/top-astrazeneca-shareholder-woodford-adds-to-stake,-bullish-on-outlook-155853
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-0.03-155865
https://uk.investing.com//news/politics-news/danish-drugmaker-novo-nordisk-bets-115-million-pounds-on-postbrexit-uk-science-152048
https://uk.investing.com//news/politics-news/drugmakers-look-for-reciprocal-ukeu-regulation-after-brexit-152972
https://uk.investing.com//news/stock-market-news/astrazeneca-faces-falling-2017-profits-as-key-drug-data-awaited-152837
https://uk.investing.com//news/stock-market-news/ftse-hits-record-highs,-extends-historic-winning-streak-148761
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.35-153264
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.51-152433
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.76-150351
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.21-151032
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.14-150088
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-0.15-150355
https://uk.investing.com//news/stock-market-news/astrazeneca-oncology-head-jumps-ship-to-become-innate-ceo-144871
https://uk.investing.com//news/stock-market-news/credit-suisse,-astrazeneca-among-top-bofa-ml's-top-european-picks-for-first-quarter-146782
https://uk.investing.com//news/stock-market-news/merck-steals-march-on-rivals-in-lung-cancer-drug-combo-race-148216
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.12-148318
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.24-143599
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.59-144372
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.08-146440
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.35-144907
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.58-147279
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.73-145296
https://uk.investing.com//news/stock-market-news/astrazeneca-in-broad-drug-deal-with-bicycle-worth-up-to-$1-billion-141608
https://uk.investing.com//news/stock-market-news/french-cancer-specialist-innate-pharma-can-remain-independent,-for-now---ceo-140575
https://uk.investing.com//news/stock-market-news/ftse-gains,-on-track-for-best-week-since-july-143212
https://uk.investing.com//news/stock-market-news/ftse-looks-set-for-third-straight-week-of-gains-140492
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.46-140581
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.79-142800
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.93-143265
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.95-141420
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.08-143037
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-0.14-140588
https://uk.investing.com//news/stock-market-news/astrazeneca's-drug-sales-weighed-on-by-flagging-crestor-137568
https://uk.investing.com//news/stock-market-news/chinese-drugmaker-invests-$36.5-million-in-british-biotech-business-kymab-140291
https://uk.investing.com//news/stock-market-news/ftse-dips-after-trump-win-though-pharma,-gold-miners-surge-137366
https://uk.investing.com//news/stock-market-news/ftse-edges-lower-as-major-firms-trade-ex-divs-140283
https://uk.investing.com//news/stock-market-news/glaxosmithkline-seeks-u.s.-approval-for-triple-lung-drug-139579
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.30-139319
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.44-139903
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.95-139080
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-1.01-136087
https://uk.investing.com//news/stock-market-news/u.s.-court-upholds-astrazeneca,-ranbaxy-win-in-nexium-antitrust-trial-139733
https://uk.investing.com//news/economy-news/it's-lonely-at-the-top-for-ftse-100-index-132287
https://uk.investing.com//news/stock-market-news/astrazeneca-cuts-brilinta-sales-hopes-on-artery-disease-failure-130492
https://uk.investing.com//news/stock-market-news/astrazeneca-licenses-respiratory-drug-to-insmed-130685
https://uk.investing.com//news/stock-market-news/astrazeneca-pauses-two-cancer-drug-trials'-enrolment-due-to-bleeding-135020
https://uk.investing.com//news/stock-market-news/britain's-ftse-hits-one-month-low,-stanchart-falls-again-135999
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.88-130496
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.55-134222
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-1.00-135840
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-0.47-135001
https://uk.investing.com//news/stock-market-news/vectura-on-lookout-for-deals-to-build-specialised-lung-drug-business-135830
https://uk.investing.com//news/stock-market-news/glaxosmithkline-to-pay-$20-million-to-settle-foreign-bribery-related-charges-129950
https://uk.investing.com//news/stock-market-news/gsk's-triple-drug-cuts-flare-ups-in-chronic-lung-disease-125322
https://uk.investing.com//news/stock-market-news/hard-to-swallow---emerging-markets-get-tougher-for-drugmakers-128328
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.25-125136
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.30-128081
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.44-125577
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.67-129663
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.97-127626
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.06-126839
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.81-127286
https://uk.investing.com//news/stock-market-news/astrazeneca-seeks-edge-over-rivals-in-severe-asthma-treatment-125011
https://uk.investing.com//news/stock-market-news/astrazeneca-to-pay-$5.52-million-to-resolve-u.s.-sec-foreign-bribery-case-123987
https://uk.investing.com//news/stock-market-news/astrazeneca-to-sell-antibiotics-business-to-pfizer-122796
https://uk.investing.com//news/stock-market-news/ftse-retreats-as-pharma-stocks-fall-123027
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.47-123334
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.79-121926
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.08-122719
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.39-124710
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.15-122525
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-0.30-123340
https://uk.investing.com//news/stock-market-news/astrazeneca-a-takeover-target-again -ceo-not-commenting-117792
https://uk.investing.com//news/stock-market-news/astrazeneca-bets-another-$140-million-on-moderna's-'messenger'-drugs-120346
https://uk.investing.com//news/stock-market-news/astrazeneca-earnings-hit-by-waning-cholesterol-drug-sales-117753
https://uk.investing.com//news/stock-market-news/astrazeneca-hits-2014-pfizer-bid-price,-helped-by-bristol's-woes-119450
https://uk.investing.com//news/stock-market-news/ftse-edges-down-from-one-year-high,-earnings-weigh-117785
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.78-120605
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.85-120108
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.19-120834
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.39-117873
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-0.48-117880
https://uk.investing.com//news/politics-news/drug-industry-ceos-lead-new-task-force-on-brexits-pharma-fallout-114055
https://uk.investing.com//news/stock-market-news/astrazeneca-resolves-faslodex-patent-litigation-in-u.s.-115005
https://uk.investing.com//news/stock-market-news/ftse-hits-11-month-peak,-miners-lead-114780
https://uk.investing.com//news/stock-market-news/judge-refuses-to-block-generic-versions-of-astrazeneca's-crestor-116187
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.33-114892
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.60-114262
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.80-114671
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.31-116840
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.33-115890
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-1.70-113614
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-eu,-latam-gout-drug-rights-to-gruenenthal-107362
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-rights-to-anaesthetics-to-south-africa's-aspen-108593
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.18-107476
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.45-111378
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.61-108265
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-1.95-110014
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-8.42-112015
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-2.54-112020
https://uk.investing.com//news/stock-market-news/u.s.-spurns-astrazeneca's-nasal-spray-flu-vaccine-as-ineffective-111416
https://uk.investing.com//news/stock-market-news/uk-stocks-reel-in-post-brexit-selloff,-ftse-set-for-worst-day-since-lehman-111503
https://uk.investing.com//news/stock-market-news/astrazeneca's-lynparza-fails-in-gastric-cancer-combination-test-104357
https://uk.investing.com//news/stock-market-news/astrazeneca-boosted-by-good-results-for-biotech-asthma-drug-104118
https://uk.investing.com//news/stock-market-news/astrazeneca-potassium-drug-delayed-by-manufacturing-snag-106318
https://uk.investing.com//news/stock-market-news/china-regulator-to-launch-drug-pricing-probe-in-june-106292
https://uk.investing.com//news/stock-market-news/french-drugmaker-sanofi-to-step-up-push-into-china-105834
https://uk.investing.com//news/stock-market-news/insight---pascal-soriot's-big-experiment:-reinventing-astrazeneca-104356
https://uk.investing.com//news/stock-market-news/novartis-splits-drugs-business-into-two,-pharma-chief-to-leave-104255
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.24-106763
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.66-106204
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.33-104253
https://uk.investing.com//news/stock-market-news/analysis---pfizer's-anacor-deal-showcases-new-wave-of-eczema-therapies-104101
https://uk.investing.com//news/stock-market-news/astrazeneca-drug-wins-orphan-status-in-thyroid-cancer-103287
https://uk.investing.com//news/stock-market-news/astrazeneca-taps-gene-pioneer-venter-for-huge-drug-hunting-sweep-99908
https://uk.investing.com//news/stock-market-news/astrazeneca-to-buy-u.s.-rights-for-gout-drug-for-up-to-$265-million-100430
https://uk.investing.com//news/stock-market-news/drugmaker-astrazeneca's-earnings-fall,-hit-by-patent-expiries-101071
https://uk.investing.com//news/stock-market-news/france's-sanofi-makes-$9.3-billion-bid-for-u.s.-biotech-medivation-100862
https://uk.investing.com//news/stock-market-news/ftse-falls,-led-lower-by-travel-and-bank-stocks-101100
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.98-104015
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.45-102664
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-investing.com-united-kingdom-100-down-0.18-102670
https://uk.investing.com//news/stock-market-news/astrazeneca-has-held-internal-talks-for-medivation-bid---sunday-times-98945
https://uk.investing.com//news/stock-market-news/ftse-lifted-by-pharma-firms-after-pfizer-deal-falls-apart-96935
https://uk.investing.com//news/stock-market-news/retail,-mining,-pharma-stocks-rally-to-boost-ftse-97144
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.04-99094
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.27-97835
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.14-97028
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-2.10-99326
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-2.56-97459
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-1.35-97237
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade;-investing.com-united-kingdom-100-up-1.19-97032
https://uk.investing.com//news/politics-news/illicit-drugs-how-brexit-risks-legal-limbo-for-medicines-94401
https://uk.investing.com//news/stock-market-news/astrazeneca-heart-drug-fails-in-key-stroke-trial-94700
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-drug-for-$70-million-as-divestment-drive-continues-90938
https://uk.investing.com//news/stock-market-news/astrazeneca-weighs-linking-ceo-pay-more-closely-to-sales-target-93072
https://uk.investing.com//news/stock-market-news/closely-watched-astrazeneca-cancer-drug-fails-in-mesothelioma-90802
https://uk.investing.com//news/stock-market-news/exclusive---makers-took-big-price-increases-on-widely-used-u.s.-drugs-96553
https://uk.investing.com//news/stock-market-news/exclusive:-pfizer-leaning-towards-abandoning-deal-with-allergan---source-96844
https://uk.investing.com//news/stock-market-news/novo-nordisk-and-astrazeneca-seek-tonic-from-key-drug-trials-91001
https://uk.investing.com//news/stock-market-news/sanofi-poaches-astrazeneca-scientist-as-new-research-head-95409
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-2.09-95761
https://uk.investing.com//news/politics-news/brexit-is-the-wrong-prescription-says-european-pharma-industry-90140
https://uk.investing.com//news/stock-market-news/astrazeneca's-$4-billion-acerta-deal-endorsed-by-orphan-drug-status-90304
https://uk.investing.com//news/stock-market-news/astrazeneca-sees-fall-in-2016-earnings-as-crestor-loss-weighs-87429
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-two-heart-drugs-to-china-medical-for-$500-million-90737
https://uk.investing.com//news/stock-market-news/astrazeneca-wins-fda-breakthrough-status-for-key-cancer-drug-89089
https://uk.investing.com//news/stock-market-news/europe-recommends-lung-cancer-drugs-from-astrazeneca,-lilly-81850
https://uk.investing.com//news/stock-market-news/european-stock-markets-push-higher;-ftse-100-rises-ahead-of-boe-87441
https://uk.investing.com//news/stock-market-news/ftse-lifted-by-a-recovery-in-its-miners-89107
https://uk.investing.com//news/stock-market-news/ftse-rallies,-but-lags-rival-european-markets-81614
https://uk.investing.com//news/stock-market-news/swedish-industry-wants-european-medicines-agency-if-uk-quits-eu-90534
https://uk.investing.com//news/stock-market-news/astrazeneca-boosts-respiratory-unit-with-$575-million-takeda-deal-81382
https://uk.investing.com//news/stock-market-news/astrazeneca-confirms-talks-with-cancer-drug-firm-acerta-80988
https://uk.investing.com//news/stock-market-news/astrazeneca-in-talks-to-buy-private-drugmaker-acerta-pharma---wsj-80837
https://uk.investing.com//news/stock-market-news/astrazeneca-investing-$800-million-to-go-local-in-china-81365
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-u.s.-drug-rights-to-perrigo-for-$380-mln-77980
https://uk.investing.com//news/stock-market-news/astrazeneca-to-buy-55-percent-of-cancer-firm-acerta-for-$4.0-billion-81595
https://uk.investing.com//news/stock-market-news/european-stocks-rally-on-fed-policy-decision;-dax-surges-2.18-81602
https://uk.investing.com//news/stock-market-news/ftse-boosted,-with-pharmaceutical-stocks-in-demand-79344
https://uk.investing.com//news/stock-market-news/pfizer-and-allergan-to-approve-merger-agreement-on-sunday---sources-77951
https://uk.investing.com//news/stock-market-news/two-decade-pfizer-mission-pays-off-for-guggenheim's-deal-king-78651
https://uk.investing.com//news/stock-market-news/astrazeneca's-new-lung-cancer-pill-to-cost-8,943-pounds-for-a-month's-supply-77278
https://uk.investing.com//news/stock-market-news/astrazeneca,-lilly-to-deepen-collaboration-on-cancer-immunotherapy-73620
https://uk.investing.com//news/stock-market-news/astrazeneca-agrees-to-buy-zs-pharma-for-$2.7-billion-75842
https://uk.investing.com//news/stock-market-news/astrazeneca-lifts-full-year-forecast-after-in-line-third-quarter-75639
https://uk.investing.com//news/stock-market-news/astrazeneca-opens-new-$224-million-drug-factory-in-russia-73283
https://uk.investing.com//news/stock-market-news/drugmakers-pfizer,-allergan-considering-a-combination---wsj-74609
https://uk.investing.com//news/stock-market-news/european-stocks-fall-on-german-data,-u.s.-rate-hike-talk;-dax-down-0.32-75656
https://uk.investing.com//news/stock-market-news/fda-staff-reviewers-question-safety-of-astrazeneca's-gout-drug-73496
https://uk.investing.com//news/stock-market-news/gsk-boss-silent-on-report-drugmaker-rebuffed-pfizer-75307
https://uk.investing.com//news/stock-market-news/shares-fall-as-egypt-worries-hit-thomas-cook-and-amec-foster-slumps-75665
https://uk.investing.com//news/stock-market-news/astrazeneca-names-genentech's-bohen-as-chief-medical-officer-65763
https://uk.investing.com//news/stock-market-news/astrazeneca-taps-crowd-sourcing-to-find-cancer-drug-cocktails-69614
https://uk.investing.com//news/stock-market-news/astrazeneca-widens-cancer-push-with-up-to-$500-million-heptares-deal-62866
https://uk.investing.com//news/stock-market-news/exclusive---transatlantic-divide:-how-u.s.-pays-three-times-more-for-drugs-72136
https://uk.investing.com//news/stock-market-news/fda-declines-approval-of-astrazeneca-diabetes-drug-combination-72772
https://uk.investing.com//news/stock-market-news/ftse-rises,-boosted-by-oil-and-mining-companies-72788
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-1.21-64175
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.41-62529
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.58-64860
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-2.54-65472
https://uk.investing.com//news/stock-market-news/astrazeneca,-cephalon-to-pay-to-resolve-medicaid-allegations---u.s-58027
https://uk.investing.com//news/stock-market-news/astrazeneca-beats-profit-forecasts,-helped-by-external-deals-61679
https://uk.investing.com//news/stock-market-news/astrazeneca-sells-rare-cancer-drug-to-sanofi-for-up-$300-million-61090
https://uk.investing.com//news/stock-market-news/celgene-to-buy-receptos-for-$7.2-billion-59308
https://uk.investing.com//news/stock-market-news/immunocore-raises-$320-million-in-record-financing-round-59532
https://uk.investing.com//news/stock-market-news/new-cocktails-to-test-limits-of-cancer-drug-pricing-62217
https://uk.investing.com//news/stock-market-news/sweden-shares-higher-at-close-of-trade;-omx-stockholm-30-up-0.35-61802
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.69-58154
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.85-57477
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-1.71-57975
https://uk.investing.com//news/stock-market-news/astrazeneca-hit-after-psoriasis-drug-linked-to-suicide-fears-50980
https://uk.investing.com//news/stock-market-news/astrazeneca-r-amp;d-boss-morrison-leaves-to-head-private-drugmaker-53807
https://uk.investing.com//news/stock-market-news/astrazeneca-to-invest-$285-million-in-swedish-biotech-factory-49716
https://uk.investing.com//news/stock-market-news/endo-international-to-buy-par-pharmaceuticals-for-$8-billion-49743
https://uk.investing.com//news/stock-market-news/london-mayor-suggests-10-billion-pound-'megafund'-to-boost-biotech-56256
https://uk.investing.com//news/stock-market-news/sweden-shares-lower-at-close-of-trade;-omx-stockholm-30-down-0.64-56310
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-ftse-100-down-0.53-53599
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-ftse-100-down-0.80-51763
https://uk.investing.com//news/stock-market-news/vectura-group-appoints-astrazeneca-executive-as-ceo-56001
https://uk.investing.com//news/technology-news/cloud-storage-provider-box-beats-street-as-more-customers-sign-up-53851
https://uk.investing.com//news/commodities-news/government-says-will-oppose-any-takeover-of-bp---ft-45962
https://uk.investing.com//news/commodities-news/government-warns-off-bp-suitors-now-shell-unavailable-as-'white-knight'-46108
https://uk.investing.com//news/stock-market-news/astrazeneca-heart-drug-results-positive-but-not-knock-out-39152
https://uk.investing.com//news/stock-market-news/astrazeneca-hit-by-copycat-nexium-and-strong-dollar-in-first-quarter-45639
https://uk.investing.com//news/stock-market-news/astrazeneca-immune-system-drug-wins-orphan-status-in-rare-cancer-43947
https://uk.investing.com//news/stock-market-news/astrazeneca-two-in-one-drug-succeeds-in-lung-disease-test-39523
https://uk.investing.com//news/stock-market-news/data-suggests-astrazeneca-drug-may-increase-death-rate---fda-43273
https://uk.investing.com//news/stock-market-news/foreign-investors-buy-uk-firms-at-fastest-pace-since-2007-40549
https://uk.investing.com//news/stock-market-news/global-cancer-drug-spending-hits-$100-billion-in-2014---ims-health-47372
https://uk.investing.com//news/stock-market-news/u.k.-shares-lower-at-close-of-trade;-ftse-100-down-1.03-46319
https://uk.investing.com//news/stock-market-news/ardelyx-kidney-drug-leads-to-increased-diarrhea-rates;-shares-fall-32393
https://uk.investing.com//news/stock-market-news/astrazeneca's-patent-on-asthma-drug-invalidated-by-u.s.-court-34634
https://uk.investing.com//news/stock-market-news/astrazeneca-keeps-2015-outlook-after-financial-reporting-change-37607
https://uk.investing.com//news/stock-market-news/astrazeneca-to-buy-actavis-lung-drugs-as-fourth-quarter-earnings-fall-short-32856
https://uk.investing.com//news/stock-market-news/astrazeneca-to-carve-out-antibiotic-r-amp;d-into-separate-firm-36428
https://uk.investing.com//news/stock-market-news/pfizer-to-buy-hospira-for-about-$15-billion-32904
https://uk.investing.com//news/stock-market-news/stryker's-$2-billion-buyback-plan-deflates-smith--amp;-nephew-bid-hopes-37097
https://uk.investing.com//news/stock-market-news/three-months-on,-fruitless-ceo-search-overshadows-sanofi-31969
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade-32978
https://uk.investing.com//news/stock-market-news/u.k.-shares-higher-at-close-of-trade-38679
https://uk.investing.com//news/stock-market-news/astrazeneca-bets-on-gene-editing-for-broad-range-of-new-drugs-31708
https://uk.investing.com//news/stock-market-news/astrazeneca-ceo-says-new-pfizer-bid-unlikely---swedish-daily-di-26738
https://uk.investing.com//news/stock-market-news/astrazeneca-heart-drug-hits-goal-in-major-clinical-trial-29118
https://uk.investing.com//news/stock-market-news/astrazeneca-in-cancer-viruses-deal-with-omnis-pharmaceuticals-28729
https://uk.investing.com//news/stock-market-news/astrazeneca loses-german-court-appeal-over-seroquel-xr-drug patent-29016
https://uk.investing.com//news/stock-market-news/elder-statesman-of-sweden's-wallenberg-dynasty-dies-29951
https://uk.investing.com//news/stock-market-news/fear-factor-fades-as-global-m-amp;a-hits-seven-year-high-26773
https://uk.investing.com//news/stock-market-news/insight---big-pharma-faces-up-to-new-price-pressure-from-aggressive-insurers-29329
https://uk.investing.com//news/stock-market-news/roche-in-$1-billion-plus-foundation-medicine-deal-to-boost-cancer-efforts-28792
https://uk.investing.com//news/stock-market-news/shake-up-at-astrazeneca-as-two-immuno-oncology-leaders-leave-27822
https://uk.investing.com//news/stock-market-news/astrazeneca,-ranbaxy-prevail-in-nexium-antitrust-trial-24988
https://uk.investing.com//news/stock-market-news/astrazeneca-not-only-game-in-town-for-deal-hungry-pfizer-22132
https://uk.investing.com//news/stock-market-news/astrazeneca-trumpets-solo-strength-in-cancer-drugs-post-pfizer-struggle-22575
https://uk.investing.com//news/stock-market-news/merck-takes-aim-at-superbugs,-to-buy-cubist-in-$9.5-billion-deal-25181
https://uk.investing.com//news/stock-market-news/neil-woodford-says-belief-in-independent-astrazeneca-'even-stronger'-22538
https://uk.investing.com//news/stock-market-news/pfizer-dampens-astra-bid-hopes-with-german-merck-cancer-deal-22380
https://uk.investing.com//news/stock-market-news/ranbaxy-sues-fda-over-revoking-approvals-for-nexium,-valcyte-copies-22586
https://uk.investing.com//news/stock-market-news/sanofi-board-to-meet-tuesday-after-sacking-ceo---sources-22471
https://uk.investing.com//news/stock-market-news/sanofi-draws-up-candidate-shortlist-for-top-job---source-22598
https://uk.investing.com//news/stock-market-news/u.s.-court-denies-ranbaxy's-bid-to-block-launch-of-rival-generics-22981
https://uk.investing.com//news/stock-market-news/astrazeneca-cancer-drug-pipeline-gets-boost-from-european-green-light-19338
https://uk.investing.com//news/stock-market-news/becton-dickinson-to-acquire-carefusion-for-$12.2-billion-in-cash,-stock-16858
https://uk.investing.com//news/stock-market-news/ftse-slumps-as-drop-in-shire-hits-healthcare-stocks-18126
https://uk.investing.com//news/stock-market-news/hedge-funds-bleed-as-abbvie-reconsiders-shire-bid-18205
https://uk.investing.com//news/stock-market-news/merck-beats-profit-forecast-with-deep-cost-cuts-19571
https://uk.investing.com//news/stock-market-news/pfizer-beats-sales-and-profit-forecasts,-mum-on-future-deals-19703
https://uk.investing.com//news/stock-market-news/pfizer-board-authorizes-$11-billion-share-repurchase-19245
https://uk.investing.com//news/stock-market-news/pfizer-execs:-new-treasury-rules-hamstring-inversion-deals-19777
https://uk.investing.com//news/stock-market-news/plant-based-vaccines-challenge-big-pharma-for-$3-billion-flu-market-16332
https://uk.investing.com//news/stock-market-news/uk-minister-says-tata-steel-unit-sale-a-commercial-matter-18342
https://uk.investing.com//news/stock-market-news/adaptimmune-raises-$104-million-to-develop-immune-system-cancer-drugs-15629
https://uk.investing.com//news/stock-market-news/astrazeneca,-shire-shares-drop-as-u.s.-tightens-tax-rules-15336
https://uk.investing.com//news/stock-market-news/astrazeneca-gets-up-to-$500-million-from-lilly-for-alzheimer's-drug-14470
https://uk.investing.com//news/stock-market-news/cost-a-focus-as-gsk-takes-lead-in-new-wave-of-biotech-lung-drugs-13513
https://uk.investing.com//news/stock-market-news/eu-agency-backs-almirall-lung-drug-being-bought-by-astrazeneca-15755
https://uk.investing.com//news/stock-market-news/ftse-to-hit-record-high-by-end-2014,-keep-rising-next-year---reuters-poll-15740
https://uk.investing.com//news/stock-market-news/healthcare-shares-knock-ftse-after-announcement-of-new-u.s.-tax-rules-15347
https://uk.investing.com//news/stock-market-news/johnson--amp;-johnson-to-buy-private-drug-developer-for-$1.75-bln-16234
https://uk.investing.com//news/stock-market-news/pfizer-approaches-actavis-to-gauge-interest-in-deal---bloomberg-15476
https://uk.investing.com//news/stock-market-news/shares-of-'inversion'-candidates-slide-on-u.s.-tax-rule-15435
https://uk.investing.com//news/stock-market-news/astrazeneca-gets-pipeline-boost-from-good-gout-drug-results-10748
https://uk.investing.com//news/stock-market-news/astrazeneca-starts-final-stage-tests-on-severe-asthma-drug-10869
https://uk.investing.com//news/stock-market-news/exclusive----quot;back-to-normal-quot;-for-astrazeneca-ceo,-despite-pfizer-rumours-12840
https://uk.investing.com//news/stock-market-news/healthcare-stocks-lift-uk's-ftse-100-11585
https://uk.investing.com//news/stock-market-news/pfizer-back-for-astrazeneca -year-end-move-seen-most-likely-11618
https://uk.investing.com//news/stock-market-news/roche-to-buy-u.s.-biotech-firm-intermune-for-$8.3-billion-11834
https://uk.investing.com//news/stock-market-news/top-uk-fund-manager-neil-woodford-sells-hsbc-stake-12665
https://uk.investing.com//news/stock-market-news/u.s.-clears-astrazeneca-over-heart-drug-trial-11335
https://uk.investing.com//news/stock-market-news/u.s.-investors-switch-out-of-europe-as-recovery-bet-sours-11070
https://uk.investing.com//news/stock-market-news/united-utilities-underperforms-as-ftse-falls-10037
https://uk.investing.com//news/stock-market-news/abbvie-succeeds-in-shire-courtship-with-$53-billion-deal-8195
https://uk.investing.com//news/stock-market-news/astrazeneca-boosts-lung-drug-business-with-up-to-$2.1-billion-almirall-deal-9240
https://uk.investing.com//news/stock-market-news/astrazeneca-results-to-get-lift-from-bid-foe-pfizer-8890
https://uk.investing.com//news/stock-market-news/astrazeneca-steps-up-push-into-cancer-immunotherapy-9458
https://uk.investing.com//news/stock-market-news/gsk-cuts-outlook-as-weak-lung-drug-sales-and-strong-pound-hit-8567
https://uk.investing.com//news/stock-market-news/pfizer's-need-for-deal-looms-larger-with-earnings-report-8998
https://uk.investing.com//news/stock-market-news/pfizer-bid-for-gsk--quot;has-some-merits-quot;,-says-berenberg-9613
https://uk.investing.com//news/stock-market-news/pfizer-leaves-investors-guessing-on-intentions-for-astra-9177
https://uk.investing.com//news/technology-news/microsoft-says-government-officials-make-sudden-visits-to-china-offices-9023
https://uk.investing.com//news/world-news/astrazeneca-smashes-forecasts-in-second-quarter-after-seeing-off-pfizer-9393
https://uk.investing.com//news/economic-indicators/fda-staff-question-validity-of-benefit-seen-with-astrazeneca-drug-6583
https://uk.investing.com//news/stock-market-news/abbvie-raises-bid-for-drugmaker-shire-to-51.15-pounds-a-share-7509
https://uk.investing.com//news/stock-market-news/astrazeneca-ceo-spends-$3.4-million-on-shares-7063
https://uk.investing.com//news/stock-market-news/cancer-drug-setback-tarnishes-astrazeneca's-r-amp;d-claims-6786
https://uk.investing.com//news/stock-market-news/ex-invesco-star-woodford's-start-up-bets-on-tobacco,-drug-firms-7338
https://uk.investing.com//news/stock-market-news/ex-morgan-stanley-banker-matlock-to-join-taubman-m-amp;a-firm-6860
https://uk.investing.com//news/stock-market-news/france-tells-investors:-just-learn-to-play-game-our-way-6726
https://uk.investing.com//news/stock-market-news/sanofi-held-talks-with-abbott,-mylan-about-mature-drugs---document-7971
https://uk.investing.com//news/stock-market-news/shire,-abbvie-to-announce-$53-billion-merger-by-friday---sources-8133
https://uk.investing.com//news/stock-market-news/syngenta-takeover-talk-ups-pressure-for-higher-returns-6636
https://uk.investing.com//news/stock-market-news/a-bitter-pill-as-china-crackdowns-squeeze-pharma-margins-5105
https://uk.investing.com//news/stock-market-news/abbvie-says-shire-rejected-bid-approach-6473
https://uk.investing.com//news/stock-market-news/astrazeneca-builds-pipeline-with-$232-million-synairgen-asthma-deal-6132
https://uk.investing.com//news/stock-market-news/astrazeneca-rejects-55-pounds-share-pfizer-offer-4514
https://uk.investing.com//news/stock-market-news/eu's-almunia:-pfizer-has-not-discussed-astrazeneca-bid-with-regulators-4439
https://uk.investing.com//news/stock-market-news/exclusive---abbvie-approaches-shire-about-possible-takeover:-sources-6456
https://uk.investing.com//news/stock-market-news/ftse-lifted-by-gains-in-arm-and-hotel-group-ihg-5205
https://uk.investing.com//news/stock-market-news/pfizer-says-keen-to-engage-with-astrazeneca-board-3969
https://uk.investing.com//news/stock-market-news/promising-cancer-drug-data-helps-astrazeneca-in-pfizer-fight-4448
https://uk.investing.com//news/stock-market-news/shire-to-set-out-astrazeneca-style-defense-against-abbvie-6574
https://uk.investing.com//news/economic-indicators/britain-wants-binding-pledges-from-pfizer-on-astrazeneca-bid-3740
https://uk.investing.com//news/economic-indicators/eu-likely-to-block-any-uk-intervention-in-astrazeneca-bid---lawyers-3658
https://uk.investing.com//news/economic-indicators/government-says-may-use-public-interest-test-in-pfizer-bid-for-astrazeneca-3420
https://uk.investing.com//news/stock-market-news/factbox---m-a-frenzy-transforming-global-pharma-3423
https://uk.investing.com//news/stock-market-news/pfizer-boss-enters-lion's-den-of-uk-politics-to-sell-astrazeneca-deal-3944
https://uk.investing.com//news/stock-market-news/pfizer-r-d-head-presses-case-for-astrazeneca-deal-3861
https://uk.investing.com//news/stock-market-news/pfizer-says-astrazeneca-takeover-would-benefit-science-3484
https://uk.investing.com//news/stock-market-news/pfizer-says-its-commitments-to-uk-legally-binding-3871
https://uk.investing.com//news/stock-market-news/uk-finance-minister-ready-for-'hard-negotiation'-with-pfizer-3799
https://uk.investing.com//news/stock-market-news/uk-labs-play-shrinking-role-in-astrazeneca-drug-portfolio-3812
https://uk.investing.com//news/economic-indicators/britain-says-talking-to-pfizer,-astrazeneca,-but-deal-is-for-shareholders-3377
https://uk.investing.com//news/economic-indicators/cbi-says-'vital'-pfizer-makes-long-term-uk-research-promise-3414
https://uk.investing.com//news/economic-indicators/mps-raise-pressure-on-pfizer-over-astrazeneca-bid-3410
https://uk.investing.com//news/economic-indicators/mps-summon-pfizer-and-astrazeneca-over-takeover-deal-3358
https://uk.investing.com//news/economic-indicators/second-mp-panel-to-call-pfizer,-astrazeneca-over-bid-3367
https://uk.investing.com//news/stock-market-news/astra-ceo-says-pfizer-bid-a-threat-to-new-drug-pipeline-3389
https://uk.investing.com//news/stock-market-news/astrazeneca,-fighting-off-pfizer,-forecasts-$45-billion-sales-by-2023-3362
https://uk.investing.com//news/stock-market-news/astrazeneca-to-step-up-discussions-with-investors-this-week-3406
https://uk.investing.com//news/stock-market-news/m-a-frenzy-in-healthcare-sector-3368
https://uk.investing.com//news/stock-market-news/pfizer-first-quarter-sales-disappoint,-generics-drag-results-3257
https://uk.investing.com//news/economic-indicators/pfizer-raises-offer-for-astrazeneca-to-50-pounds-share-3080
https://uk.investing.com//news/economic-indicators/pfizer-raises-offer-for-astrazeneca-to-50-pounds-share-3082
https://uk.investing.com//news/stock-market-news/analysis---pfizer-u.s-research-jobs-jeopardised-by-promises-to-uk-for-merger-3187
https://uk.investing.com//news/stock-market-news/astrazeneca-board-meeting-friday-to-weigh-new-pfizer-bid-sources-3109
https://uk.investing.com//news/stock-market-news/astrazeneca-rejects-latest-pfizer-approach-3116
https://uk.investing.com//news/stock-market-news/astrazeneca-says-board-will-review-pfizer-offer-3091
https://uk.investing.com//news/stock-market-news/big-pharma-stands-to-profit-by-cleaning-out-its-medicine-chests-3203
https://uk.investing.com//news/stock-market-news/britain-says-considering-pfizer's-reassurances-in-astra-battle-3122
https://uk.investing.com//news/stock-market-news/pfizer's-science-vows-to-britain:-promise-or-placebo -3142
https://uk.investing.com//news/stock-market-news/uk-government-says-pfizer's-astrazeneca-bid-a-decision-for-shareholders-3094
